10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 26, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      To                    

Commission File Number: 0-12906

RICHARDSON ELECTRONICS, LTD.

(Exact name of registrant as specified in its charter)

Delaware	36-2096643
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

40W267 Keslinger Road, P.O. Box 393 

LaFox, Illinois 60147-0393

(Address of principal executive offices)

Registrant’s telephone number, including area code: (630) 208-2200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.05 Par Value	RELL	NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒ Yes ☐ No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒ Yes    ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-Accelerated Filer	☒	Smaller Reporting Company	☒
Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐ Yes   ☒ No

As of April 5, 2022, there were outstanding 11,608,236 shares of Common Stock, $0.05 par value and 2,053,263 shares of Class B Common Stock, $0.05 par value, which are convertible into Common Stock of the registrant on a share for share basis.

TABLE OF CONTENTS

		Page
Part I.	Financial Information
Item 1.	Financial Statements	2
	Consolidated Balance Sheets	2
	Unaudited Consolidated Statements of Comprehensive Income	3
	Unaudited Consolidated Statements of Cash Flows	4
	Unaudited Consolidated Statement of Stockholders’ Equity	5
	Notes to Unaudited Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25
Item 4.	Controls and Procedures	25
Part II.	Other Information
Item 1.	Legal Proceedings	26
Item 1A.	Risk Factors	26
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 5.	Other Information	26
Item 6.	Exhibits	27
Exhibit Index		27
Signatures		28

1

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS 

Richardson Electronics, Ltd.

Consolidated Balance Sheets

(in thousands, except per share amounts)

	Unaudited		Audited
	February 26, 2022		May 29, 2021
Assets
Current assets:
Cash and cash equivalents	$	39,147	$	43,316
Accounts receivable, less allowance of $149 and $202, respectively		31,605		25,096
Inventories, net		73,673		63,508
Prepaid expenses and other assets		3,362		2,385
Total current assets		147,787		134,305
Non-current assets:
Property, plant and equipment, net		16,839		17,067
Intangible assets, net		2,077		2,270
Lease ROU asset		3,502		2,570
Non-current deferred income taxes		481		541
Total non-current assets		22,899		22,448
Total assets	$	170,686	$	156,753
Liabilities
Current liabilities:
Accounts payable	$	20,744	$	16,979
Accrued liabilities		15,975		14,182
Lease liability current		1,164		1,066
Total current liabilities		37,883		32,227
Non-current liabilities:
Non-current deferred income tax liabilities		235		242
Lease liability non-current		2,113		1,358
Other non-current liabilities		844		1,366
Total non-current liabilities		3,192		2,966
Total liabilities		41,075		35,193
Stockholders’ Equity
Common stock, $0.05 par value; issued and outstanding 11,608 shares on    February 26, 2022 and 11,160 shares on May 29, 2021		580		558
Class B common stock, convertible, $0.05 par value; issued and outstanding    2,053 shares on February 26, 2022 and 2,097 shares on May 29, 2021		103		105
Preferred stock, $1.00 par value, no shares issued		—		—
Additional paid-in-capital		65,831		62,707
Retained earnings		60,557		53,297
Accumulated other comprehensive income		2,540		4,893
Total stockholders’ equity		129,611		121,560
Total liabilities and stockholders’ equity	$	170,686	$	156,753

2

Richardson Electronics, Ltd.

Unaudited Consolidated Statements of Comprehensive Income

(in thousands, except per share amounts)

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Net sales	$	55,308		$	45,235		$	162,991		$	126,465
Cost of sales		37,739			29,469			111,468			83,997
Gross profit		17,569			15,766			51,523			42,468
Selling, general and administrative expenses		13,946			15,457			40,550			41,924
Loss (gain) on disposal of assets		—			(6	)		2			(6	)
Operating income		3,623			315			10,971			550
Other expense (income):
Investment/interest income		(11	)		(15	)		(36	)		(48	)
Foreign exchange loss (gain)		121			65			(2	)		650
Other, net		17			(25	)		39			(61	)
Total other expense		127			25			1			541
Income before income taxes		3,496			290			10,970			9
Income tax provision		609			62			1,326			239
Net income (loss)		2,887			228			9,644			(230	)
Foreign currency translation gain (loss), net of tax		69			353			(2,353	)		2,966
Comprehensive income	$	2,956		$	581		$	7,291		$	2,736
Net income (loss) per share:
Common shares - Basic	$	0.22		$	0.02		$	0.73		$	(0.02	)
Class B common shares - Basic		0.19			0.02			0.66			(0.02	)
Common shares - Diluted		0.21			0.02			0.71			(0.02	)
Class B common shares - Diluted		0.19			0.02			0.64			(0.02	)
Weighted average number of shares:
Common shares – Basic		11,497			11,111			11,320			11,097
Class B common shares – Basic		2,074			2,097			2,089			2,097
Common shares – Diluted		12,027			11,183			11,724			11,097
Class B common shares – Diluted		2,074			2,097			2,089			2,097
Dividends per share:
Common share	$	0.060		$	0.060		$	0.180		$	0.180
Class B common share		0.054			0.054			0.162			0.162

3

Richardson Electronics, Ltd.

Unaudited Consolidated Statements of Cash Flows

(in thousands)

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Operating activities:
Net income (loss)	$	2,887		$	228		$	9,644		$	(230	)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
Depreciation and amortization		872			849			2,560			2,595
Inventory provisions		88			265			228			717
Share-based compensation expense		142			150			514			529
Loss (gain) on disposal of assets		—			(6	)		2			(6	)
Deferred income taxes		26			3			38			(50	)
Change in assets and liabilities:
Accounts receivable		(4,209	)		(837	)		(7,355	)		(1,004	)
Inventories		(3,113	)		133			(12,295	)		(875	)
Prepaid expenses and other assets		(2	)		428			(1,058	)		156
Accounts payable		1,902			496			4,204			(2,027	)
Accrued liabilities		563			873			2,075			4,285
Other		(370	)		216			(13	)		(222	)
Net cash (used in) provided by operating activities		(1,214	)		2,798			(1,456	)		3,868
Investing activities:
Capital expenditures		(554	)		(555	)		(2,161	)		(1,835	)
Proceeds from maturity of investments		—			—			—			16,000
Purchases of investments		—			—			—			(9,000	)
Net cash (used in) provided by investing activities		(554	)		(555	)		(2,161	)		5,165
Financing activities:
Proceeds from issuance of common stock		1,906			—			2,630			—
Cash dividends paid		(806	)		(780	)		(2,384	)		(2,340	)
Payment of financing lease principal		(45	)		(45	)		(136	)		(136	)
Net cash provided by (used in) financing activities		1,055			(825	)		110			(2,476	)
Effect of exchange rate changes on cash and cash equivalents		195			(34	)		(662	)		1,315
(Decrease) increase in cash and cash equivalents		(518	)		1,384			(4,169	)		7,872
Cash and cash equivalents at beginning of period		39,665			37,023			43,316			30,535
Cash and cash equivalents at end of period	$	39,147		$	38,407		$	39,147		$	38,407

4

Richardson Electronics, Ltd.

Unaudited Consolidated Statement of Stockholders’ Equity

(in thousands, except per share amounts)

	Common		Class B Common			Par Value		Additional Paid In Capital			Retained Earnings			Accumulated Other Comprehensive Income			Total
Balance May 29, 2021:		11,160		2,097		$	663	$	62,707		$	53,297		$	4,893		$	121,560
Comprehensive income:
Net income		—		—			—		—			9,644			—			9,644
Foreign currency translation		—		—			—		—						(2,353	)		(2,353	)
Share-based compensation:
Restricted stock		—		—			—		339			—			—			339
Stock options		—		—			—		175			—			—			175
Common stock:
Options exercised		331		—			16		2,614			—			—			2,630
Restricted stock issuance		73		—			4		(4	)		—			—			—
Class B converted to Common		44		(44	)		—		—			—			—			—
Dividends paid to:
Common ($0.180 per share)		—		—			—		—			(2,047	)		—			(2,047	)
Class B ($0.162 per share)		—		—			—		—			(337	)		—			(337	)
Balance February 26, 2022		11,608		2,053		$	683	$	65,831		$	60,557		$	2,540		$	129,611
Balance November 27, 2021:		11,338		2,097		$	672	$	63,794		$	58,476		$	2,471		$	125,413
Comprehensive income:
Net income		—		—			—		—			2,887			—			2,887
Foreign currency translation		—		—			—		—			—			69			69
Share-based compensation:
Restricted stock		—		—			—		105			—			—			105
Stock options		—		—			—		37			—			—			37
Common stock:
Options exercised		226		—			11		1,895			—			—			1,906
Class B converted to Common		44		(44	)		—		—			—			—			—
Dividends paid to:
Common ($0.060 per share)		—		—			—		—			(695	)		—			(695	)
Class B ($0.054 per share)		—		—			—		—			(111	)		—			(111	)
Balance February 26, 2022		11,608		2,053		$	683	$	65,831		$	60,557		$	2,540		$	129,611

5

	Common		Class B Common		Par Value		Additional Paid In Capital			Retained Earnings			Accumulated Other Comprehensive Income		Total
Balance May 30, 2020:		11,038		2,097	$	657	$	61,749		$	54,764		$	1,490	$	118,660
Comprehensive income:
Net loss		—		—		—		—			(230	)		—		(230	)
Foreign currency translation		—		—		—		—			—			2,966		2,966
Share-based compensation:
Restricted stock		—		—		—		371			—			—		371
Stock options		—		—		—		158			—			—		158
Common stock:
Restricted stock issuance		73		—		4		(4	)		—			—		—
Dividends paid to:
Common ($0.180 per share)		—		—		—		—			(2,000	)		—		(2,000	)
Class B ($0.162 per share)		—		—		—		—			(340	)		—		(340	)
Balance February 27, 2021		11,111		2,097	$	661	$	62,274		$	52,194		$	4,456	$	119,585
Balance November 28, 2020:		11,111		2,097	$	661	$	62,124		$	52,746		$	4,103	$	119,634
Comprehensive income:
Net income		—		—		—		—			228			—		228
Foreign currency translation		—		—		—		—			—			353		353
Share-based compensation:
Restricted stock		—		—		—		112			—			—		112
Stock options		—		—		—		38			—			—		38
Dividends paid to:
Common ($0.060 per share)		—		—		—		—			(667	)		—		(667	)
Class B ($0.054 per share)		—		—		—		—			(113	)		—		(113	)
Balance February 27, 2021		11,111		2,097	$	661	$	62,274		$	52,194		$	4,456	$	119,585

6

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1.  DESCRIPTION OF THE COMPANY

Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes, and service training for diagnostic imaging equipment; and customized display solutions. More than 60% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world.  All our partners manufacture to our strict specifications and per our supplier code of conduct. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure.

Our products include electron tubes and related components, microwave generators, subsystems used in semiconductor manufacturing and visual technology solutions. These products are used to control, switch or amplify electrical power signals, or are used as display devices in a variety of industrial, commercial, medical and communication applications.

We have three operating and reportable segments, which we define as follows:

Power and Microwave Technologies Group (“PMT”) combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America.

2.  BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements.

Our fiscal quarter ends on the Saturday nearest the end of the quarter-ending month. The third quarter of fiscal 2022 and fiscal 2021 both contained 13 weeks. The first nine months of fiscal 2022 and fiscal 2021 both contained 39 weeks.

In the opinion of management, all adjustments, which are of a normal and recurring nature, necessary for a fair presentation of the results of interim periods have been made. All inter-company transactions and balances have been eliminated. The unaudited consolidated financial statements presented herein include the accounts of our wholly owned subsidiaries. Certain information and

7

note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of our operations for the three months and nine months ended February 26, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending May 28, 2022.

The financial information contained in this report should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, which was filed on August 2, 2021.

3.  CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Inventories, net: Our consolidated inventories were stated at the lower of cost and net realizable value, generally using a weighted-average cost method. Our net inventories include approximately $62.1 million of finished goods, $7.0 million of raw materials and $4.6 million of work-in-progress as of February 26, 2022, as compared to approximately $57.0 million of finished goods, $3.9 million of raw materials and $2.6 million of work-in-progress as of May 29, 2021.

At this time, we do not anticipate any material risks or uncertainties related to possible future inventory write-downs. Provisions for obsolete or slow-moving inventories are recorded based upon regular analysis of stock rotation privileges, obsolescence, the exiting of certain markets and assumptions about future demand and market conditions. If future demand changes in the industry, or market conditions differ from management’s estimates, additional provisions may be necessary. Inventory reserves were approximately $5.9 million as of February 26, 2022 and $5.9 million as of May 29, 2021.

Revenue Recognition: The Company’s revenue streams include distribution, manufacturing and service revenue. The distribution business does not include a separate service bundled with the product sold or sold on top of the product. Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers. Revenue is recognized when control of the promised goods is transferred to our customers, which is simultaneous with the title transferring to the customer, in an amount that reflects the transaction price consideration that we expect to receive in exchange for those goods. Control refers to the ability of the customer to direct the use of, and obtain substantially all of, the remaining benefits from the goods. Our transaction price consideration is fixed, unless otherwise disclosed below as variable consideration. Generally, our contracts require our customers to pay for goods after we deliver products to them. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America subject to customary credit checks.

The Company also sells products that are manufactured or assembled in our manufacturing facility. These products can either be built to the customer’s prints/designs or are products that we stock in our warehouse to sell to any customer that places an order. The manufacturing business does not include a separate service bundled with the product sold or sold in addition to the product.

The Company recognizes services revenue when the repair, installation or training is performed. The services we provide are relatively short in duration and typically completed in one or two weeks. Therefore, at each reporting date, the amount of unbilled work is insignificant. The services revenue has consistently accounted for less than 5% of the Company’s total revenues and is expected to continue at that level.

We also record discounts taken and estimate returns based on historical experience. Our products are often manufactured to meet the specific design needs of our customers’ applications. Our engineers work closely with customers to ensure that our products will meet their needs. Our customers are under no obligation to compensate us for designing the products we sell.

Contracts with customers

A revenue contract exists once a customer purchase order is received, reviewed and accepted. Prior to accepting a customer purchase order, we review the credit worthiness of the customer. Purchase orders are deemed to meet the collectability criterion once the customer’s credit is approved.

Contract Liabilities: Contract liabilities and revenue recognized were as follows (in thousands):

	May 29, 2021		Additions		Revenue Recognized			February 26, 2022
Contract liabilities (deferred revenue)	$	3,313	$	5,071	$	(3,956	)	$	4,428

The Company receives advance payments or deposits from our customers before revenue is recognized resulting in contract liabilities. Contract liabilities are included in accrued liabilities in the consolidated balance sheets.

Performance obligations and satisfaction of performance obligation in the contract

Each accepted purchase order identifies a distinct good or service as the performance obligation. The goods are generally standard products we purchased from a supplier and stocked on our shelves. They can also be customized products purchased from a supplier or products that are customized or have value added to them in house prior to shipping to the customer. Our contracts for customized products generally include termination provisions if a customer cancels its order. However, we recognize revenue at a point in time because the termination provisions do not require, upon cancelation, the customer to pay fees that are commensurate with the work performed. Each purchase order explicitly states the goods or service that we promise to transfer to the customer. The promises to the customer are limited only to those goods or service. The performance obligation is our promise to deliver both goods

8

that were produced by the Company and resale of goods that we purchase from our suppliers. Our shipping and handling activities for destination shipments are performed prior to the customer obtaining control. As such, they are not a separate promised service. For shipping point, the Company is making the election under ASC 606-10-25-18B to account for shipping and handling as activities to fulfill the promise to transfer the goods. The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit. The goods are also distinct in that each item sold to the customer is clearly identified on both the purchase order and resulting invoice. Each product we sell benefits the customer independently of the other products. Each item on each purchase order from the customer can be used by the customer unrelated to any other products we provide to the customer.

Determine the transaction price and variable consideration

The transaction price for each product is the amount invoiced to the customer. Each product on a purchase order is a separate performance obligation with an observable standalone selling price. The transaction price is a fixed price per unit, except for the variable consideration. The Company elects to exclude sales tax from the transaction price.

Recognize revenue when the entity satisfies a performance obligation

We recognize revenue at a point in time when title transfers to the customer, at the shipping point for FOB shipping contracts and at the customer’s delivery location for FOB destination contracts. We believe that the transfer of title best represents when the customer obtains control of the goods. Prior to that date, we do not have right to payment, and the significant risks and rewards remain with us. The significant risks and rewards of ownership of the inventory transfer simultaneously with the transfer of title. The customer’s acceptance of the goods is based on objective measurements, not subjective.

Additional considerations

Sale with right of return:

Our return policy is available to customers in our terms and conditions found on our website www.rell.com. The policy varies by business unit. The Company allows returns with prior written authorization and we allow returns within ten days of shipment for replacement parts.  

The Company maintains a reserve for returns based on historical trends that covers all contracts and revenue streams using the expected value method because we have a large number of contracts with similar characteristics, which is considered variable consideration. The reserve for returns creates a refund liability on our balance sheet as a contra Trade Accounts Receivable as well as an asset in inventory. We value the inventory at cost due to there being minimal or no costs to the Company as we generally require the customer to pay freight and we typically do not have costs associated with activities such as relabeling or repackaging.

The reserve is considered immaterial at each balance sheet date for further consideration. Returns for defective product are typically covered by our suppliers’ warranty, thus, returns for defective product are not factored into our reserve.

Warranties:

We offer warranties for the limited number of specific products we manufacture. For further information regarding the impact of warranties see the Warranties discussion elsewhere in Note 3.

Principal versus agent considerations:

Principal versus agent guidance was considered for customized products that are provided by our suppliers versus manufactured by the Company. The Company acts as the principal as we are responsible for satisfying the performance obligation. We have primary responsibility for fulfilling the contract, we have inventory risk prior to delivery to our customer, we establish prices, our consideration is not in the form of a commission and we bear the credit risk. The Company recognizes revenue in the gross amount of consideration.

See Note 7, Segment Reporting, for a disaggregation of revenue by reportable segment and geographic region, which represents how our chief operating decision maker reviews information internally to evaluate our financial performance and to make resource allocation and other decisions for the Company.

9

Loss Contingencies: We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. If we determine that there is at least a reasonable possibility that a loss may have been incurred, we will include a disclosure describing the contingency.

Intangible Assets: Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. Intangible assets that have finite useful lives are amortized over their useful lives either on a straight-line basis or over their projected future cash flows and are tested for impairment when events or changes in circumstances occur that indicate possible impairment. Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with the acquisitions. Intangible assets subject to amortization were as follows (in thousands):

	February 26, 2022		May 29, 2021
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships(1)		3,410		3,426
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,476	$	4,492
Accumulated Amortization:
Trade Name	$	659	$	659
Customer Relationships		1,409		1,249
Non-compete Agreements		177		177
Technology		154		137
Total Accumulated Amortization	$	2,399	$	2,222
Net Intangible Assets	$	2,077	$	2,270

(1) Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands): 

Fiscal Year	Amortization Expense
Remaining 2022	$	63
2023		246
2024		232
2025		219
2026		185
Thereafter		1,132
Total amortization	$	2,077

The weighted average number of years of amortization expense remaining is 12.2 years.

Income Taxes: We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review our deferred tax assets for recoverability and determine the need for a valuation allowance based on a number of factors, including both positive and negative evidence. These factors include historical taxable income or loss, projected future taxable income or loss, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. In circumstances where we, or any of our affiliates, have incurred three years of cumulative losses which constitute significant negative evidence, positive evidence of equal or greater significance is needed to overcome the negative evidence before a tax benefit is recognized for deductible temporary differences and loss carryforwards.

10

Accrued Liabilities: Accrued liabilities consisted of the following (in thousands):

	February 26, 2022		May 29, 2021
Compensation and payroll taxes	$	4,740	$	4,945
Accrued severance		678		685
Professional fees		614		533
Deferred revenue		4,428		3,313
Other accrued expenses		5,515		4,706
Accrued Liabilities	$	15,975	$	14,182

Warranties: We offer warranties for the limited number of specific products we manufacture. Our warranty terms generally range from one to three years.

We estimate the cost to perform under the warranty obligation and recognize this estimated cost at the time of the related product sale. We record expense related to our warranty obligations as cost of sales in our consolidated statements of comprehensive income. Each quarter, we assess actual warranty costs incurred on a product-by-product basis and compare the warranty costs to our estimated warranty obligation. With respect to new products, estimates are based generally on knowledge of the products and warranty experience, if a sufficient history exists.

Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. Warranty reserves are included in accrued liabilities on our consolidated balance sheets. The warranty reserves are determined based on known product failures, historical experience and other available evidence. Warranty reserves were approximately $0.7 million as of February 26, 2022 and $0.5 million as of May 29, 2021.

4.  LEASE OBLIGATIONS AND OTHER COMMITMENTS

The Company leases real and personal property in the normal course of business under various operating leases and financing leases. The Company has two types of operating leases: leases for facility space and leases for automobiles. Most of the leased facility space is for sales and general office use. Automobile leases are used throughout the Company. The financing lease is for our computer servers.

The gross amounts of assets and liabilities related to both operating and financing leases were as follows (in thousands):

Lease Type	February 26, 2022		May 29, 2021
Operating lease ROU asset	$	3,263	$	2,262
Financing lease ROU asset		239		308
Total lease ROU asset	$	3,502	$	2,570
Operating lease liability current	$	1,149	$	918
Financing lease liability current		15		148
Total lease liability current	$	1,164	$	1,066
Operating lease liability non-current	$	2,113	$	1,358
Total lease liability non-current	$	2,113	$	1,358

11

The components of lease costs were as follows (in thousands):

		Three Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	452	$	484
Consolidated financing lease amortization	Operating expenses		23		23
Consolidated financing lease interest	Interest expense		1		2
Consolidated financing lease expense			24		25
Net lease cost		$	476	$	509

		Nine Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	1,353	$	1,474
Consolidated financing lease amortization	Operating expenses		69		69
Consolidated financing lease interest	Interest expense		4		9
Consolidated financing lease expense			73		78
Net lease cost		$	1,426	$	1,552

The approximate future minimum lease payments under operating and financing leases at February 26, 2022 were as follows (in thousands):

Fiscal Year	Operating Leases		Financing Leases		Total
Remaining 2022	$	338	$	15	$	353
2023		1,218		—		1,218
2024		838		—		838
2025		586		—		586
2026		401		—		401
Thereafter		94		—		94
Total lease payments		3,475		15		3,490
Less imputed interest		213		—		213
Net minimum lease payments	$	3,262	$	15	$	3,277

The weighted average remaining lease terms and interest rates of leases held by the Company as of February 26, 2022 were as follows:

Lease Type	Weighted Average Remaining Lease Term in Years	Weighted Average Interest Rate
Operating leases	3.4	4.5%
Financing leases	0.1	4.6%

The cash outflows of the leasing activity of the Company as lessee for the nine months ending February 26, 2022 and February 27, 2021 were as follows (in thousands):

		Nine Months Ended
Cash Flow Source	Classification	February 26, 2022		February 27, 2021
Operating cash flows from operating leases	Operating activities	$	986	$	430
Operating cash flows from financing leases	Operating activities		133		127
Finance cash flows from financing leases	Financing activities		136		136

12

5.  INCOME TAXES

We recorded an income tax provision of $1.3 million and $0.2 million for the first nine months of fiscal 2022 and the first nine months of fiscal 2021, respectively. The increase in the tax provision from fiscal 2021 reflects higher foreign taxes, geographical distribution of income (loss) and state income tax provision due to temporary suspension of net operating loss utilization in Illinois and California.

In the normal course of business, we are subject to examination by taxing authorities throughout the world. Generally, years prior to fiscal 2015 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We are currently under examination in Thailand (fiscal 2008 through 2011) and Germany (fiscal 2015 through 2018). Our primary foreign tax jurisdictions are Germany and the Netherlands. We have tax years open in Germany beginning in fiscal 2015 and the Netherlands beginning in fiscal 2018.

We have historically determined that certain undistributed earnings of our foreign subsidiaries, to the extent of cash available, will be repatriated to the U.S. The deferred tax liability on the outside basis difference is now primarily withholding tax on future dividend distributions. We have provided a deferred tax liability of less than $0.1 million as of both February 26, 2022 and as of May 29, 2021.

As of February 26, 2022 and as of May 29, 2021, our worldwide liability for uncertain tax positions related to continuing operations was $0.1 million, excluding interest and penalties. We record penalties and interest related to uncertain tax positions in the income tax expense line item within the consolidated statements of comprehensive income.

The valuation allowance against the net deferred tax assets that will more likely than not be realized was $9.6 million as of February 26, 2022. The valuation allowance against the net deferred tax assets was $12.2 million as of May 29, 2021 and the Company is utilizing prior losses in the first three quarters of fiscal 2022 against its income. A full valuation allowance on the U.S. and state deferred tax assets will be maintained until sufficient positive evidence related to sources of future taxable income exists to support a reversal of the valuation allowance. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are increased, or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as our projections for growth.

6.  CALCULATION OF EARNINGS PER SHARE

We have authorized 17,000,000 shares of common stock and 3,000,000 shares of Class B common stock. The Class B common stock has 10 votes per share and has transferability restrictions; however, Class B common stock may be converted into common stock on a share-for-share basis at any time. With respect to dividends and distributions, shares of common stock and Class B common stock rank equally and have the same rights, except that Class B common stock cash dividends are limited to 90% of the amount of common stock cash dividends.

Our Class B common stock is considered a participating security requiring the use of the two-class method for the computation of basic and diluted earnings per share. The two-class computation method for each period reflects the cash dividends paid per share for each class of stock, plus the amount of allocated undistributed earnings per share computed using the participation percentage which reflects the dividend rights of each class of stock. Basic and diluted earnings per share were computed using the two-class method. The shares of Class B common stock are considered to be participating convertible securities since the shares of Class B common stock are convertible on a share-for-share basis into shares of common stock and may participate in dividends with common stock according to a predetermined formula which is 90% of the amount of common stock cash dividends.

13

The earnings per share (“EPS”) presented in our unaudited consolidated statements of comprehensive income were based on the following amounts (in thousands, except per share amounts):

	Three Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income	$	2,887	$	2,887	$	228		$	228
Less dividends:
Common stock		695		695		667			667
Class B common stock		111		111		113			113
Undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Common stock undistributed earnings (loss)	$	1,790	$	1,801	$	(472	)	$	(472	)
Class B common stock undistributed earnings (loss)		291		280		(80	)		(80	)
Total undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,497		11,497		11,111			11,111
Effect of dilutive securities
Dilutive stock options				530					72
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				12,027					11,183
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,074		2,074		2,097			2,097
Net income per share:
Common stock	$	0.22	$	0.21	$	0.02		$	0.02
Class B common stock	$	0.19	$	0.19	$	0.02		$	0.02

Note: There were no common stock options that were antidilutive in the third quarter of fiscal 2022 and fiscal 2021.

14

	Nine Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income (loss)	$	9,644	$	9,644	$	(230	)	$	(230	)
Less dividends:
Common stock		2,047		2,047		2,000			2,000
Class B common stock		337		337		340			340
Undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Common stock undistributed earnings (loss)	$	6,226	$	6,257	$	(2,196	)	$	(2,196	)
Class B common stock undistributed earnings (loss)		1,034		1,003		(374	)		(374	)
Total undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,320		11,320		11,097			11,097
Effect of dilutive securities
Dilutive stock options				404					—
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				11,724					11,097
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,089		2,089		2,097			2,097
Net income (loss) per share:
Common stock	$	0.73	$	0.71	$	(0.02	)	$	(0.02	)
Class B common stock	$	0.66	$	0.64	$	(0.02	)	$	(0.02	)

Note: There were no common stock options that were antidilutive in the first nine months of fiscal 2022. Common stock options that were anti-dilutive and not included in the diluted earnings per common share for the first nine months of fiscal 2021 were 1,300.

7.  SEGMENT REPORTING

We have identified three reportable segments as follows:

PMT combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

15

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

The CEO, who is the chief operating decision maker, evaluates performance and allocates resources primarily based on the gross profit of each segment.

Operating results by segment are summarized in the following table (in thousands):

	Three Months Ended				Nine Months Ended
	February 26, 2022		February 27, 2021		February 26, 2022		February 27, 2021
PMT
Net Sales	$	44,032	$	35,237	$	128,778	$	98,418
Gross Profit		14,163		12,308		41,080		33,530
Canvys
Net Sales		8,141		7,078		25,732		20,491
Gross Profit		2,618		2,493		8,348		7,156
Healthcare
Net Sales		3,135		2,920		8,481		7,556
Gross Profit		788		965		2,095		1,782

Geographic net sales information is primarily grouped by customer destination into five areas: North America; Asia/Pacific; Europe; Latin America; and Other.

Net sales and gross profit by geographic region are summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Net Sales
North America	$	23,647		$	19,654		$	68,615		$	53,513
Asia/Pacific		13,275			9,821			38,220			28,970
Europe		16,067			13,285			48,231			37,277
Latin America		2,380			2,446			7,976			6,591
Other (1)		(61	)		29			(51	)		114
Total	$	55,308		$	45,235		$	162,991		$	126,465
Gross Profit
North America	$	8,946		$	8,081		$	24,984		$	21,099
Asia/Pacific		4,061			3,517			12,126			9,592
Europe		4,884			4,356			14,507			12,153
Latin America		917			896			2,998			2,345
Other (1)		(1,239	)		(1,084	)		(3,092	)		(2,721	)
Total	$	17,569		$	15,766		$	51,523		$	42,468

(1) Other includes primarily net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.

We sell our products to customers in diversified industries and perform periodic credit evaluations of our customers’ financial condition. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America. Estimates of credit losses are recorded in the financial statements based on monthly reviews of outstanding accounts.

8. RISKS AND UNCERTAINTIES

Company Response to COVID-19

In March 2020, the World Health Organization classified the outbreak of COVID-19 as a pandemic. Thereafter, most U.S. states imposed “shelter in place” or similar directives on their populations to stem the spread of COVID-19 and similar restrictive

16

measures were taken by governments across the world. Throughout the duration of such restrictions, the Company was considered a critical supplier of products to healthcare and critical infrastructure businesses and, accordingly, the Company continued our manufacturing and distribution operations as an “essential business” throughout the implementation of various restrictions on operations in our fiscal 2021 and beyond. Our top priority was ensuring the health and safety of our employees and, accordingly, we undertook measures such as limiting the number of people in any one of our facilities by requiring only employees who could not perform their work remotely to physically work in a Company US-based facility. The Company advised all other employees that could perform their job functions remotely to do so. As such, the Company’s operations have remained operational during the pandemic.

The impact of the COVID-19 outbreak and its effects continue to evolve. As such, the full magnitude that the pandemic, its effects, and the steps taken to prevent and/or mitigate its spread or otherwise address its impact, will have on the Company’s financial condition, liquidity and future results of operations is uncertain. The extent of the impact of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the duration and spread of the pandemic, the extent, speed and effectiveness of worldwide containment and vaccination effort, any subsequent wave or waves of outbreaks, and the impact of these and other factors on our employees, customers and suppliers. Our ability to meet customer demands for products may be impaired or, similarly, our customers may experience adverse business consequences due to COVID-19 and its effects. Reduced demand for products or impaired ability to meet customer demand (including disruptions at our transportation service providers or vendors or otherwise in our supply chain) could have a material adverse effect on our business, operations and financial performance. While we had some COVID-19 related component delays impacting new product development schedules, we did not experience a major interruption in our supply chain. Management continues to monitor the global situation on its financial condition, liquidity, operations, suppliers, industry and workforce. Given the ever-evolving nature of the pandemic and the continued global responses to curb its spread, the Company is not presently able to fully estimate the effects of COVID-19 on its results of operations, financial condition or liquidity for fiscal year 2022.

Company Response to CARES Act

On March 27, 2020, Congress enacted the Coronavirus Aid, Relief and Economic Security (“CARES”) Act to provide certain relief as a result of the COVID-19 outbreak. The CARES Act included provisions relating to refundable payroll tax credits, deferral of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, increased limitations on qualified charitable contributions and technical corrections to tax depreciation methods for qualified, improvement property. As of February 26, 2022, the Company deferred $0.5 million of employer-side social security tax payments. The Company has estimated and recorded the overall effects of the CARES Act and does not anticipate a material change.

9. FAIR VALUE MEASUREMENTS

Investments are measured at fair value. The Company had no investments as of February 26, 2022 and May 29, 2021.

10. RELATED PARTY TRANSACTION

On June 15, 2015, the Company entered into a lease agreement for the IMES facility with LDL, LLC. That lease agreement was extended for five years in fiscal 2021. The Company shall be entitled to extend the term of the lease for a period of an additional five years by notifying the landlord in writing of its intention to do so within six months of the expiration of the term. The Executive Vice President of IMES, Lee A. McIntyre III (former owner of IMES), has an ownership interest in LDL, LLC. The lease agreement provides for monthly payments over five years with total future minimum lease payments of $0.5 million. Rental expense related to this lease amounted to $0.1 million for the nine months ended February 26, 2022 and February 27, 2021.

17

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Certain statements in this report may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. The terms “may,” “should,” “could,” “anticipate,” “believe,” “continues,” “estimate,” “expect,” “intend,” “objective,” “plan,” “potential,” “project” and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on management’s current expectations, intentions or beliefs and are subject to a number of factors, assumptions and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause or contribute to such differences or that might otherwise impact the business include; economic, labor and political systems and conditions; global business disruption caused by the Russia invasion in Ukraine and related sanctions: currency exchange fluctuations; and the ability of the Company to manage its growth and the risk factors set forth in our Annual Report on Form 10-K filed on August 2, 2021 We undertake no obligation to update any such factor or to publicly announce the results of any revisions to any forward-looking statements contained herein whether as a result of new information, future events or otherwise.

In addition, while we do, from time to time, communicate with securities analysts, it is against our policy to disclose to them any material non-public information or other confidential commercial information. Accordingly, stockholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report. Thus, to the extent that reports issued by securities analysts contain any projections, forecasts or opinions, such reports are not our responsibility.

INTRODUCTION

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to assist the reader in better understanding our business, results of operations, financial condition, changes in financial condition and significant developments. MD&A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes appearing elsewhere in this filing. This section is organized as follows:

• Business Overview

• Results of Operations – an analysis and comparison of our consolidated results of operations for the three and nine month periods ended February 26, 2022 and February 27, 2021, as reflected in our consolidated statements of comprehensive income.

• Liquidity, Financial Position and Capital Resources – a discussion of our primary sources and uses of cash for the nine month periods ended February 26, 2022 and February 27, 2021, and a discussion of changes in our financial position.

Business Overview

Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes, and service training for diagnostic imaging equipment; and customized display solutions. More than 60% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world.  All our partners manufacture to our strict specifications and per our supplier code of conduct. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure.

Some of the Company's products are manufactured in China and are imported into the United States. The Office of the United States Trade Representative ("USTR") instituted additional 10% to 25% tariffs on the importation of a number of products into the United States from China effective July 6, 2018, with additional products added August 23, 2018 and September 24, 2018. These additional tariffs are a response to what the USTR considers to be certain unfair trade practices by China. A number of the Company's products manufactured in China are now subject to these additional duties of 25% when imported into the United States.

Management continues to work with its suppliers as well as its customers to mitigate the impact of the tariffs on our customers’ markets. However, if the Company is unable to successfully pass through the additional cost of these tariffs, or if the higher prices reduce demand for the Company's products, it will have a negative effect on the Company's sales and gross margins.

18

We have three operating and reportable segments, which we define as follows:

Power and Microwave Technologies Group (“PMT”) combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. Our volume commitments are lower than the large display manufacturers, making us the ideal choice for companies with very specific design requirements. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America.

RESULTS OF OPERATIONS

Financial Summary – Three Months Ended February 26, 2022

• The third quarter of fiscal 2022 and fiscal 2021 each contained 13 weeks.

• Net sales during the third quarter of fiscal 2022 were $55.3 million, an increase of 22.3%, compared to net sales of $45.2 million during the third quarter of fiscal 2021.

• Gross margin decreased to 31.8% during the third quarter of fiscal 2022 compared to 34.9% during the third quarter of fiscal 2021.

• Selling, general and administrative expenses were $13.9 million or 25.2% of net sales, during the third quarter of fiscal 2022 compared to $15.5 million, including the $1.6 million legal settlement, or 34.2% of net sales, during the third quarter of fiscal 2021.

• Operating income during the third quarter of fiscal 2022 was $3.6 million compared to $0.3 million during the third quarter of fiscal 2021.

• Net income during the third quarter of fiscal 2022 was $2.9 million compared to $0.2 million during the third quarter of fiscal 2021.

19

Financial Summary – Nine Months Ended February 26, 2022

• The first nine months of fiscal 2022 and fiscal 2021 each contained 39 weeks.

• Net sales during the first nine months of fiscal 2022 were $163.0 million, an increase of 28.9%, compared to net sales of $126.5 million during the first nine months of fiscal 2021.

• Gross margin decreased to 31.6% during the first nine months of fiscal 2022 compared to 33.6% during the first nine months of fiscal 2021.

• Selling, general and administrative expenses were $40.6 million or 24.9% of net sales, during the first nine months of fiscal 2022 compared to $41.9 million, including the $1.6 million legal settlement, or 33.2% of net sales, during the first nine months of fiscal 2021.

• Operating income during the first nine months of fiscal 2022 was $11.0 million compared to $0.6 million during the first nine months of fiscal 2021.

• Net income during the first nine months of fiscal 2022 was $9.6 million compared to a net loss of $0.2 million during the first nine months of fiscal 2021.  

Net Sales and Gross Profit Analysis

Net sales by segment and percent change during the third quarter and first nine months of fiscal 2022 and fiscal 2021 were as follows (in thousands):

Net Sales	Three Months Ended				FY22 vs. FY21
	February 26, 2022		February 27, 2021		% Change
PMT	$	44,032	$	35,237		25.0	%
Canvys		8,141		7,078		15.0	%
Healthcare		3,135		2,920		7.4	%
Total	$	55,308	$	45,235		22.3	%

	Nine Months Ended				FY22 vs. FY21
	February 26, 2022		February 27, 2021		% Change
PMT	$	128,778	$	98,418		30.8	%
Canvys		25,732		20,491		25.6	%
Healthcare		8,481		7,556		12.2	%
Total	$	162,991	$	126,465		28.9	%

During the third quarter of fiscal 2022, consolidated net sales increased 22.3% compared to the third quarter of fiscal 2021. Sales for PMT increased 25.0%, sales for Canvys increased 15.0% and sales for Healthcare increased 7.4%. The increase in PMT was mainly due to strong growth from our Power and Microwave new technology partners in various applications including Power Management and 5G infrastructure as well as increased shipments of our ULTRA3000. We also had growth in various Electron Device product lines. The increase in Canvys was primarily due to strong sales in the European and North American markets. The increase in Healthcare was primarily due to increases in part sales and an increase in demand for the ALTA750^TM tubes.

During the first nine months of fiscal 2022, consolidated net sales increased 28.9% compared to the first nine months of fiscal 2021. Sales for PMT increased 30.8%, sales for Canvys increased 25.6% and sales for Healthcare increased 12.2%. The increase in PMT was mainly due to strong growth from our Power and Microwave new technology partners in various applications including Power Management and 5G infrastructure and increased revenue from our Semiconductor Wafer Fabrication customers buying engineered solutions. We also had growth in various Electron Device product lines. The increase in Canvys was primarily due to strong sales in the European and North American markets. The increase in Healthcare was primarily due to an increase in demand for the ALTA750^TM tubes.

20

Gross profit by segment and percent of net sales for the third quarter and first nine months of fiscal 2022 and fiscal 2021 were as follows (in thousands):

Gross Profit	Three Months Ended
	February 26, 2022		% of Net Sales			February 27, 2021		% of Net Sales
PMT	$	14,163		32.2	%	$	12,308		34.9	%
Canvys		2,618		32.2	%		2,493		35.2	%
Healthcare		788		25.1	%		965		33.0	%
Total	$	17,569		31.8	%	$	15,766		34.9	%

	Nine Months Ended
	February 26, 2022		% of Net Sales			February 27, 2021		% of Net Sales
PMT	$	41,080		31.9	%	$	33,530		34.1	%
Canvys		8,348		32.4	%		7,156		34.9	%
Healthcare		2,095		24.7	%		1,782		23.6	%
Total	$	51,523		31.6	%	$	42,468		33.6	%

Gross profit reflects the distribution and manufacturing product margin less manufacturing variances, inventory obsolescence charges, customer returns, scrap and cycle count adjustments, engineering costs and other provisions.

Consolidated gross profit increased to $17.6 million during the third quarter of fiscal 2022 compared to $15.8 million during the third quarter of fiscal 2021. Consolidated gross margin as a percentage of net sales decreased to 31.8% during the third quarter of fiscal 2022 from 34.9% during the third quarter of fiscal 2021, primarily due to product mix in PMT, higher freight costs in Canvys and increased component scrap expense and higher freight costs in Healthcare.

Consolidated gross profit increased to $51.5 million during the first nine months of fiscal 2022 compared to $42.5 million during the first nine months of fiscal 2021. Consolidated gross margin as a percentage of net sales decreased to 31.6% during the first nine months of fiscal 2022 from 33.6% during the first nine months of fiscal 2021, primarily due to product mix in PMT and higher freight costs in Canvys.

Power and Microwave Technologies Group

PMT net sales increased 25.0% to $44.0 million during the third quarter of fiscal 2022 from $35.2 million during the third quarter of fiscal 2021. The increase was mainly due to strong growth from our Power and Microwave new technology partners in various applications including Power Management and 5G infrastructure as well as increased shipments of our ULTRA3000. We also had growth in various Electron Device product lines. Gross margin as a percentage of net sales decreased to 32.2% during the third quarter of fiscal 2022 as compared to 34.9% during the third quarter of fiscal 2021 due to product mix.

PMT net sales increased 30.8% to $128.8 million during the first nine months of fiscal 2022 from $98.4 million during the first nine months of fiscal 2021. The increase was mainly due to strong growth from our Power and Microwave new technology partners in various applications including Power Management and 5G infrastructure and increased revenue from our Semiconductor Wafer Fabrication customers buying engineered solutions. We also had growth in various Electron Device product lines. Gross margin as a percentage of net sales decreased to 31.9% during the first nine months of fiscal 2022 as compared to 34.1% during the first nine months of fiscal 2021 due to product mix.

Canvys

Canvys net sales increased 15.0% to $8.1 million during the third quarter of fiscal 2022 from $7.1 million during the third quarter of fiscal 2021 primarily due to strong sales in the European as well as the North American markets. Gross margin as a percentage of net sales decreased to 32.2% during the third quarter of fiscal 2022 from 35.2% during the third quarter of fiscal 2021 due to the increasing freight costs resulting from the COVID-19 pandemic.

Canvys net sales increased 25.6% to $25.7 million during the first nine months of fiscal 2022 from $20.5 million during the first nine months of fiscal 2021 primarily due to strong sales in the European as well as the North America markets. Gross margin as a percentage of net sales decreased to 32.4% during the first nine months of fiscal 2022 from 34.9% during the first nine months of fiscal 2021 due to the increasing freight costs resulting from the COVID-19 pandemic.

21

Healthcare

Healthcare net sales increased 7.4% to $3.1 million during the third quarter of fiscal 2022 from $2.9 million during the third quarter of fiscal 2021 primarily due to increases in part sales as well as an increase in demand for the ALTA750^TM tubes. Gross margin as a percentage of net sales decreased to 25.1% during the third quarter of fiscal 2022 as compared to 33.0% during the third quarter of fiscal 2021 primarily due to increased component scrap expense in addition to rising freight costs resulting from the COVID-19 pandemic.

Healthcare net sales increased 12.2% to $8.5 million during the first nine months of fiscal 2022 from $7.6 million during the first nine months of fiscal 2021. The increase in sales was primarily due to an increase in demand for the ALTA750^TM tubes. Gross margin as a percentage of net sales increased to 24.7% during the first nine months of fiscal 2022 as compared to 23.6% during the first nine months of fiscal 2021 primarily due to favorable product mix partially offset by rising freight costs resulting from the COVID-19 pandemic.      

Legal Settlement – Fiscal 2021

On April 2, 2021, as part of a settlement where the Company did not admit liability, Richardson agreed to pay Varex Imaging Corporation (“Varex”) $1.6 million to settle those claims. This settlement was recorded in selling, general and administrative expenses within the Consolidated Statements of Comprehensive Income for the third quarter of fiscal 2021.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased to $13.9 million during the third quarter of fiscal 2022 from $15.5 million in the third quarter of fiscal 2021. The decrease was mainly due to the non-recurrence in fiscal 2022 of the $1.6 million legal settlement recorded in fiscal 2021. The foregoing section discusses the fiscal 2021 legal settlement. In addition, higher employee compensation expenses were offset by lower legal fees.

Selling, general and administrative expenses decreased to $40.6 million during the first nine months of fiscal 2022 from $41.9 million in the first nine months of fiscal 2021. The decrease was mainly due to the non-recurrence in fiscal 2022 of the $1.6 million legal settlement recorded in fiscal 2021. The foregoing section discusses the fiscal 2021 legal settlement. In addition, higher employee compensation expenses were partially offset by lower legal fees.

Other Income/Expense

Other expense was $0.1 million during the third quarter of fiscal 2022, compared to less than $0.1 million for the third quarter of fiscal 2021. Other expense during the third quarter of fiscal 2022 was mainly a foreign exchange loss, as investment income was offset by other expenses. Our foreign exchange gains and losses are primarily due to the translation of U.S. dollars held in non-U.S. entities. We currently do not utilize derivative instruments to manage our exposure to foreign currency.

Other expense was less than $0.1 million during the first nine months of fiscal 2022, compared to $0.5 million for the first nine months of fiscal 2021. For the first nine months of fiscal 2022 investment income was more than offset by other expenses and the foreign exchange gain was minimal.

Income Tax Provision

The income tax provision was $0.6 million and $0.1 million for the third quarter of fiscal 2022 and the third quarter of fiscal 2021, respectively. The difference in the tax provision for the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021 reflects higher foreign taxes, changes in our geographical distribution of income (loss) and state income tax provision due to temporary suspension of net operating loss utilization in Illinois and California.

We recorded an income tax provision of $1.3 million and $0.2 million for the first nine months of fiscal 2022 and the first nine months of fiscal 2021, respectively. The difference in the tax provision for the first nine months of fiscal 2022 as compared to the first nine months of fiscal 2021 reflects higher foreign taxes, changes in our geographical distribution of income (loss) and state income tax provision due to temporary suspension of net operating loss utilization in Illinois and California.

In the normal course of business, we are subject to examination by taxing authorities throughout the world. Generally, years prior to fiscal 2015 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We are currently under examination in Thailand (fiscal 2008 through 2011) and Germany (fiscal 2015 through 2018). Our primary foreign tax jurisdictions are Germany and the Netherlands. We have tax years open in Germany beginning in fiscal 2015 and the Netherlands beginning in fiscal 2018.

22

Net Income (Loss) and Per Share Data

Net income during the third quarter of fiscal 2022 was $2.9 million, or $0.21 per diluted common share and $0.19 per Class B diluted common share as compared to $0.2 million during the third quarter of fiscal 2021 or $0.02 per diluted common share and $0.02 per Class B diluted common share.

Net income during the first nine months of fiscal 2022 was $9.6 million, or $0.71 per diluted common share and $0.64 per Class B diluted common share as compared to net loss of $0.2 million during the first nine months of fiscal 2021 or ($0.02) per diluted common share and ($0.02) per Class B diluted common share.

LIQUIDITY, FINANCIAL POSITION AND CAPITAL RESOURCES

Our operations and cash needs have been primarily financed through income from operations and cash on hand.

Cash and cash equivalents were $39.1 million at February 26, 2022. Cash and cash equivalents by geographic area at February 26, 2022 consisted of $25.2 million in North America, $7.1 million in Europe, $1.4 million in Latin America and $5.4 million in Asia/Pacific. We repatriated $1.5 million to the United States in fiscal 2022. This amount includes $0.7 million in the first quarter from our entity in China, $0.3 million in the second quarter from our entity in Taiwan and $0.5 million in the third quarter from our entity in Japan. Although the Tax Cuts and Jobs Act generally eliminated federal income tax on future cash repatriation to the United States, cash repatriation may be subject to state and local taxes, withholding or similar taxes. See Note 7, Income Taxes of the notes to our consolidated financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, filed August 2, 2021 for further information.

Cash and cash equivalents were $43.3 million at May 29, 2021. Cash and cash equivalents by geographic area at May 29, 2021, consisted of $26.1 million in North America, $8.8 million in Europe, $1.2 million in Latin America and $7.2 million in Asia/Pacific. We repatriated a total of $0.9 million to the United States in fiscal 2021 from several of our foreign entities. This amount includes $0.7 million from our entities in Italy and South Korea in the third quarter of fiscal 2021 and $0.2 million from our entity in France in the fourth quarter of fiscal 2021.

The Company continues to monitor the impact of COVID-19, including the extent, duration and effectiveness of containment actions taken, the speed and extent of vaccination programs, as well as other global developments (including geopolitical tensions and the current conflict between Ukraine and Russia) and their impact on the Company’s supply chain, manufacturing and distribution operations, customers and employees, as well as the U.S. and world economy in general. However, due to the uncertain and constantly evolving impacts of the COVID-19 pandemic and other disruptions that have created extreme volatility in the capital markets and may continue to have further global economic consequences across the globe, the Company cannot currently predict the long-term impact on its operations and financial results. The uncertainties associated with the COVID-19 pandemic and its effects, along with other global volatility, include potential adverse effects on the overall economy, the Company's supply chain, transportation services, employees and customers, as well as the Company's revenues, earnings, liquidity and cash flows and may require significant actions in response, including expense reductions. Conditions surrounding COVID-19 and other matters of global concern change rapidly and additional impacts of which the Company is not currently aware may arise. Based on past performance and current expectations, we believe that the existing sources of liquidity, including current cash, will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve months.

Cash Flows from Operating Activities

Cash flows from operating activities primarily resulted from our net income (loss) adjusted for non-cash items and changes in our operating assets and liabilities.

Operating activities used $1.5 million of cash during the first nine months of fiscal 2022. We had a net income of $9.6 million during the first nine months of fiscal 2022, which included non-cash stock-based compensation expense of $0.5 million associated with the issuance of stock option and restricted stock awards, inventory reserve provisions of $0.2 million and depreciation and amortization expense of $2.6 million associated with our property and equipment as well as amortization of our intangible assets. Changes in our operating assets and liabilities used $14.4 million in cash during the first nine months of fiscal 2022, net of foreign currency exchange gains and losses, included an increase in accounts receivable of $7.4 million, an increase in inventory of $12.3 million and an increase in prepaid expenses of $1.1 million. Partially offsetting the cash utilization for accounts receivable, inventory and prepaid expenses was an increase in accounts payable and accrued liabilities of $6.3 million. The increase in accounts receivable was primarily due to increased sales. The majority of the inventory increase was to support the growth in LaFox manufacturing and the RF and microwave components business. The increase in accounts payable was related to the inventory increase and the increase in accrued liabilities was timing related.

23

Operating activities provided $3.9 million of cash during the first nine months of fiscal 2021. We had a net loss of $0.2 million during the first nine months of fiscal 2021, which included non-cash stock-based compensation expense of $0.5 million associated with the issuance of stock option and restricted stock awards, $0.7 million for inventory reserve provisions and depreciation and amortization expense of $2.6 million associated with our property and equipment as well as amortization of our intangible assets. Changes in our operating assets and liabilities resulted in cash provided of $0.3 million during the first nine months of fiscal 2021, net of foreign currency exchange gains and losses, included an increase in accrued liabilities of $4.3 million, partially offset by a decrease of $2.0 million in accounts payable, an increase in accounts receivable of $1.0 million and an increase in inventory of $0.9 million. The increase in accrued liabilities was mainly due to a legal settlement and timing of employee compensation and payroll tax payments as well as the timing of other payments. The decrease in our accounts payable was due to timing of payments for some of our larger vendors for both inventory and services. The increase in accounts receivable was primarily due to the sales increase in fiscal 2021. The majority of the inventory increase was to support the electron tube and RF and microwave components business.

Cash Flows from Investing Activities

Cash flows from investing activities consisted primarily of capital expenditures and purchases and maturities of investments. Our purchases and proceeds from investments consist of time deposits and CDs. The purchasing of future investments varies from period to period due to interest and foreign currency exchange rates.

Cash used in investing activities of $2.2 million during the first nine months of fiscal 2022 was due to capital expenditures. Capital expenditures were primarily related to our Healthcare business, IT system and manufacturing facilities. The Company did not have any investment purchases or maturities in the first nine months of fiscal 2022.

Cash provided by investing activities of $5.2 million during the first nine months of fiscal 2021 included proceeds from the maturities of investments of $16.0 million, partially offset by purchases of investments of $9.0 million and $1.8 million in capital expenditures. Capital expenditures were primarily related to our Healthcare business and IT system.

Cash Flows from Financing Activities

Cash flows used in financing activities consisted primarily of cash dividends and cash flows provided by financing activities consisted primarily of the proceeds from the issuance of stock.

Cash provided by financing activities of $0.1 million during the first nine months of fiscal 2022 primarily resulted from the $2.6 million proceeds from the issuance of stock less the $2.4 million of dividend payments to stockholders.

Cash used in financing activities of $2.5 million during the first nine months of fiscal 2021 primarily resulted from cash used to pay dividends.

All future payments of dividends are at the discretion of the Board of Directors. Dividend payments will depend on earnings, capital requirements, operating conditions and such other factors that the Board may deem relevant.

24

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Risk Management and Market Sensitive Financial Instruments

We are exposed to many different market risks with the various industries we serve. The primary financial risk we are exposed to is foreign currency exchange, as certain operations, assets and liabilities of ours are denominated in foreign currencies. We manage these risks through normal operating and financing activities.

The interpretation and analysis of these disclosures should not be considered in isolation since such variances in exchange rates would likely influence other economic factors. Such factors, which are not readily quantifiable, would likely also affect our operations. Additional disclosure regarding various market risks are set forth in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, filed August 2, 2021.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Management of the Company, with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of February 26, 2022.

Disclosure controls and procedures are intended to provide reasonable assurance that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

(b) Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the third quarter of fiscal 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

25

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, filed August 2, 2021.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 5. OTHER INFORMATION

26

ITEM 6. EXHIBITS

Exhibit Index

Exhibit Number	Description
3.1	Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Annex III of the Proxy Statement dated August 22, 2014).
3.2	Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 15, 2017).
31.1	Certification of Edward J. Richardson pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Robert J. Ben pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from our Quarterly Report on Form 10-Q for the third quarter of fiscal 2022, filed with the SEC on April 7, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets, (ii) the Unaudited Consolidated Statements of Comprehensive Income, (iii) the Unaudited Consolidated Statements of Cash Flows, (iv) the Unaudited Consolidated Statement of Stockholders’ Equity and (v) Notes to Unaudited Consolidated Financial Statements.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

27

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RICHARDSON ELECTRONICS, LTD.
Date: April 7, 2022	By:	/s/ Robert J. Ben
		Robert J. Ben Chief Financial Officer and Chief Accounting Officer (on behalf of the Registrant and as Principal Financial Officer)

28

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Edward J. Richardson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Richardson Electronics, Ltd. for the period ended February 26, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 7, 2022
Signature:	/s/ Edward J. Richardson
Edward J. Richardson
Chairman of the Board and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Robert J. Ben, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Richardson Electronics, Ltd. for the period ended February 26, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 7, 2022
Signature:	/s/ Robert J. Ben
Robert J. Ben
Chief Financial Officer and Chief Accounting Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Richardson Electronics, Ltd. (the “Company”) on Form 10-Q for the period ended February 26, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward J. Richardson, Chairman of the Board and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Edward J. Richardson

Edward J. Richardson

Chairman of the Board and Chief Executive Officer

April 7, 2022

CERTIFICATION PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Richardson Electronics, Ltd. (the “Company”) on Form 10-Q for the period ended February 26, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert J. Ben, Chief Financial Officer and Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Robert J. Ben

Robert J. Ben

Chief Financial Officer and Chief Accounting Officer

April 7, 2022

XML

Document and Entity Information - shares	9 Months Ended
	Feb. 26, 2022	Apr. 05, 2022
Document Information [Line Items]
Entity Registrant Name	RICHARDSON ELECTRONICS, LTD.
Entity Central Index Key	0000355948
Document Type	10-Q
Trading Symbol	RELL
Document Period End Date	Feb. 26, 2022
Amendment Flag	false
Current Fiscal Year End Date	--05-28
Entity's Reporting Status Current	Yes
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Small Business	true
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Entity File Number	0-12906
Entity Tax Identification Number	36-2096643
Entity Address, Address Line One	40W267 Keslinger Road
Entity Address, Address Line Two	P.O. Box 393
Entity Address, City or Town	LaFox
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60147-0393
City Area Code	630
Local Phone Number	208-2200
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock, $0.05 Par Value
Security Exchange Name	NASDAQ
Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		11,608,236
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		2,053,263

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Feb. 26, 2022	May 29, 2021
Current assets:
Cash and cash equivalents	$ 39,147	$ 43,316
Accounts receivable, less allowance of $149 and $202, respectively	31,605	25,096
Inventories, net	73,673	63,508
Prepaid expenses and other assets	3,362	2,385
Total current assets	147,787	134,305
Non-current assets:
Property, plant and equipment, net	16,839	17,067
Intangible assets, net	2,077	2,270
Lease ROU asset	3,502	2,570
Non-current deferred income taxes	481	541
Total non-current assets	22,899	22,448
Total assets	170,686	156,753
Current liabilities:
Accounts payable	20,744	16,979
Accrued liabilities	15,975	14,182
Lease liability current	1,164	1,066
Total current liabilities	37,883	32,227
Non-current liabilities:
Non-current deferred income tax liabilities	235	242
Lease liability non-current	2,113	1,358
Other non-current liabilities	844	1,366
Total non-current liabilities	3,192	2,966
Total liabilities	41,075	35,193
Stockholders’ Equity
Preferred stock, $1.00 par value, no shares issued
Additional paid-in-capital	65,831	62,707
Retained earnings	60,557	53,297
Accumulated other comprehensive income	2,540	4,893
Total stockholders’ equity	129,611	121,560
Total liabilities and stockholders’ equity	170,686	156,753
Common Stock
Stockholders’ Equity
Common stock, $0.05 par value; issued and outstanding 11,608 shares on February 26, 2022 and 11,160 shares on May 29, 2021 Class B common stock, convertible, $0.05 par value; issued and outstanding2,053 shares on February 26, 2022 and 2,097 shares on May 29, 2021	580	558
Common Class B
Stockholders’ Equity
Common stock, $0.05 par value; issued and outstanding 11,608 shares on February 26, 2022 and 11,160 shares on May 29, 2021 Class B common stock, convertible, $0.05 par value; issued and outstanding2,053 shares on February 26, 2022 and 2,097 shares on May 29, 2021	$ 103	$ 105

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Feb. 26, 2022	May 29, 2021
Allowance for accounts receivable	$ 149	$ 202
Preferred stock, par value (in dollars per share)	$ 1.00	$ 1.00
Preferred Stock, issued (in shares)	0	0
Common Stock
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, issued (in shares)	11,608	11,160
Common stock, outstanding (in shares)	11,608	11,160
Common Class B
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, issued (in shares)	2,053	2,097
Common stock, outstanding (in shares)	2,053	2,097

XML

Unaudited Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021
Net sales	$ 55,308	$ 45,235	$ 162,991	$ 126,465
Cost of sales	37,739	29,469	111,468	83,997
Gross profit	17,569	15,766	51,523	42,468
Selling, general and administrative expenses	13,946	15,457	40,550	41,924
Loss (gain) on disposal of assets		(6)	2	(6)
Operating income	3,623	315	10,971	550
Other expense (income):
Investment/interest income	(11)	(15)	(36)	(48)
Foreign exchange loss (gain)	121	65	(2)	650
Other, net	17	(25)	39	(61)
Total other expense	127	25	1	541
Income before income taxes	3,496	290	10,970	9
Income tax provision	609	62	1,326	239
Net income (loss)	2,887	228	9,644	(230)
Foreign currency translation gain (loss), net of tax	69	353	(2,353)	2,966
Comprehensive income	$ 2,956	$ 581	$ 7,291	$ 2,736
Weighted average number of shares:
Common shares - Diluted	12,027	11,183
Common Stock
Net income (loss) per share:
Common shares - Basic	$ 0.22	$ 0.02	$ 0.73	$ (0.02)
Common shares - Diluted	$ 0.21	$ 0.02	$ 0.71	$ (0.02)
Weighted average number of shares:
Common shares - Basic	11,497	11,111	11,320	11,097
Common shares - Diluted	12,027	11,183	11,724	11,097
Dividends per share:
Dividends per share	$ 0.060	$ 0.060	$ 0.180	$ 0.180
Common Class B
Net income (loss) per share:
Common shares - Basic	0.19	0.02	0.66	(0.02)
Common shares - Diluted	$ 0.19	$ 0.02	$ 0.64	$ (0.02)
Weighted average number of shares:
Common shares - Basic	2,074	2,097	2,089	2,097
Common shares - Diluted	2,074	2,097	2,089	2,097
Dividends per share:
Dividends per share	$ 0.054	$ 0.054	$ 0.162	$ 0.162

XML

Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021
Operating activities:
Net income (loss)	$ 2,887	$ 228	$ 9,644	$ (230)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
Depreciation and amortization	872	849	2,560	2,595
Inventory provisions	88	265	228	717
Share-based compensation expense	142	150	514	529
Loss (gain) on disposal of assets		(6)	2	(6)
Deferred income taxes	26	3	38	(50)
Change in assets and liabilities:
Accounts receivable	(4,209)	(837)	(7,355)	(1,004)
Inventories	(3,113)	133	(12,295)	(875)
Prepaid expenses and other assets	(2)	428	(1,058)	156
Accounts payable	1,902	496	4,204	(2,027)
Accrued liabilities	563	873	2,075	4,285
Other	(370)	216	(13)	(222)
Net cash (used in) provided by operating activities	(1,214)	2,798	(1,456)	3,868
Investing activities:
Capital expenditures	(554)	(555)	(2,161)	(1,835)
Proceeds from maturity of investments				16,000
Purchases of investments				(9,000)
Net cash (used in) provided by investing activities	(554)	(555)	(2,161)	5,165
Financing activities:
Proceeds from issuance of common stock	1,906		2,630
Cash dividends paid	(806)	(780)	(2,384)	(2,340)
Payment of financing lease principal	(45)	(45)	(136)	(136)
Net cash provided by (used in) financing activities	1,055	(825)	110	(2,476)
Effect of exchange rate changes on cash and cash equivalents	195	(34)	(662)	1,315
(Decrease) increase in cash and cash equivalents	(518)	1,384	(4,169)	7,872
Cash and cash equivalents at beginning of period	39,665	37,023	43,316	30,535
Cash and cash equivalents at end of period	$ 39,147	$ 38,407	$ 39,147	$ 38,407

XML

Unaudited Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common	Common Class B	Common Stock	Common Stock Common	Common Stock Common Class B	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning Balance at May. 30, 2020	$ 118,660			$ 657			$ 61,749	$ 54,764	$ 1,490
Beginning Balance (in shares) at May. 30, 2020					11,038	2,097
Comprehensive income:
Net income (loss)	(230)							(230)
Foreign currency translation	2,966								2,966
Share-based compensation:
Restricted stock	371						371
Stock options	158						158
Restricted stock issuance				4			(4)
Restricted stock issuance (in shares)					73
Dividends paid to:
Common ($0.180 per share)	(2,000)							(2,000)
Class B ($0.162 per share)	(340)							(340)
Ending Balance at Feb. 27, 2021	119,585			661			62,274	52,194	4,456
Ending Balance (in shares) at Feb. 27, 2021					11,111	2,097
Beginning Balance at Nov. 28, 2020	119,634			661			62,124	52,746	4,103
Beginning Balance (in shares) at Nov. 28, 2020					11,111	2,097
Comprehensive income:
Net income (loss)	228							228
Foreign currency translation	353								353
Share-based compensation:
Restricted stock	112						112
Stock options	38						38
Dividends paid to:
Common ($0.180 per share)	(667)							(667)
Class B ($0.162 per share)	(113)							(113)
Ending Balance at Feb. 27, 2021	119,585			661			62,274	52,194	4,456
Ending Balance (in shares) at Feb. 27, 2021					11,111	2,097
Beginning Balance at May. 29, 2021	121,560			663			62,707	53,297	4,893
Beginning Balance (in shares) at May. 29, 2021		11,160	2,097		11,160	2,097
Comprehensive income:
Net income (loss)	9,644							9,644
Foreign currency translation	(2,353)								(2,353)
Share-based compensation:
Restricted stock	339						339
Stock options	175						175
Options exercised	2,630			16	$ 331		2,614
Restricted stock issuance				4			(4)
Restricted stock issuance (in shares)					73
Class B Converted to common (in shares)					44	(44)
Dividends paid to:
Common ($0.180 per share)	(2,047)							(2,047)
Class B ($0.162 per share)	(337)							(337)
Ending Balance at Feb. 26, 2022	129,611			683			65,831	60,557	2,540
Ending Balance (in shares) at Feb. 26, 2022		11,608	2,053		11,608	2,053
Beginning Balance at Nov. 27, 2021	125,413			672			63,794	58,476	2,471
Beginning Balance (in shares) at Nov. 27, 2021					11,338	2,097
Comprehensive income:
Net income (loss)	2,887							2,887
Foreign currency translation	69								69
Share-based compensation:
Restricted stock	105						105
Stock options	37						37
Options exercised	1,906			11	$ 226		1,895
Class B Converted to common (in shares)					44	(44)
Dividends paid to:
Common ($0.180 per share)	(695)							(695)
Class B ($0.162 per share)	(111)							(111)
Ending Balance at Feb. 26, 2022	$ 129,611			$ 683			$ 65,831	$ 60,557	$ 2,540
Ending Balance (in shares) at Feb. 26, 2022		11,608	2,053		11,608	2,053

XML

Unaudited Consolidated Statement of Stockholders' Equity (Parenthetical) - Common Stock - $ / shares	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021
Common
Dividends per common share	$ 0.060	$ 0.060	$ 0.180	$ 0.180
Common Class B
Dividends per common share	$ 0.054	$ 0.054	$ 0.162	$ 0.162

XML

Description of the Company

9 Months Ended

Feb. 26, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of the Company

1.  DESCRIPTION OF THE COMPANY

Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes, and service training for diagnostic imaging equipment; and customized display solutions. More than 60% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world.  All our partners manufacture to our strict specifications and per our supplier code of conduct. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure.

Our products include electron tubes and related components, microwave generators, subsystems used in semiconductor manufacturing and visual technology solutions. These products are used to control, switch or amplify electrical power signals, or are used as display devices in a variety of industrial, commercial, medical and communication applications.

We have three operating and reportable segments, which we define as follows:

Power and Microwave Technologies Group (“PMT”) combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America.

XML

Basis of Presentation

9 Months Ended

Feb. 26, 2022

Basis Of Presentation [Abstract]

Basis of Presentation

2.  BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements.

Our fiscal quarter ends on the Saturday nearest the end of the quarter-ending month. The third quarter of fiscal 2022 and fiscal 2021 both contained 13 weeks. The first nine months of fiscal 2022 and fiscal 2021 both contained 39 weeks.

In the opinion of management, all adjustments, which are of a normal and recurring nature, necessary for a fair presentation of the results of interim periods have been made. All inter-company transactions and balances have been eliminated. The unaudited consolidated financial statements presented herein include the accounts of our wholly owned subsidiaries. Certain information and

note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of our operations for the three months and nine months ended February 26, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending May 28, 2022.

The financial information contained in this report should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended May 29, 2021, which was filed on August 2, 2021.

XML

Critical Accounting Policies and Estimates

9 Months Ended

Feb. 26, 2022

Accounting Policies [Abstract]

Critical Accounting Policies and Estimates

3.  CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Inventories, net: Our consolidated inventories were stated at the lower of cost and net realizable value, generally using a weighted-average cost method. Our net inventories include approximately $62.1 million of finished goods, $7.0 million of raw materials and $4.6 million of work-in-progress as of February 26, 2022, as compared to approximately $57.0 million of finished goods, $3.9 million of raw materials and $2.6 million of work-in-progress as of May 29, 2021.

At this time, we do not anticipate any material risks or uncertainties related to possible future inventory write-downs. Provisions for obsolete or slow-moving inventories are recorded based upon regular analysis of stock rotation privileges, obsolescence, the exiting of certain markets and assumptions about future demand and market conditions. If future demand changes in the industry, or market conditions differ from management’s estimates, additional provisions may be necessary. Inventory reserves were approximately $5.9 million as of February 26, 2022 and $5.9 million as of May 29, 2021.

Revenue Recognition: The Company’s revenue streams include distribution, manufacturing and service revenue. The distribution business does not include a separate service bundled with the product sold or sold on top of the product. Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers. Revenue is recognized when control of the promised goods is transferred to our customers, which is simultaneous with the title transferring to the customer, in an amount that reflects the transaction price consideration that we expect to receive in exchange for those goods. Control refers to the ability of the customer to direct the use of, and obtain substantially all of, the remaining benefits from the goods. Our transaction price consideration is fixed, unless otherwise disclosed below as variable consideration. Generally, our contracts require our customers to pay for goods after we deliver products to them. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America subject to customary credit checks.

The Company also sells products that are manufactured or assembled in our manufacturing facility. These products can either be built to the customer’s prints/designs or are products that we stock in our warehouse to sell to any customer that places an order. The manufacturing business does not include a separate service bundled with the product sold or sold in addition to the product.

The Company recognizes services revenue when the repair, installation or training is performed. The services we provide are relatively short in duration and typically completed in one or two weeks. Therefore, at each reporting date, the amount of unbilled work is insignificant. The services revenue has consistently accounted for less than 5% of the Company’s total revenues and is expected to continue at that level.

We also record discounts taken and estimate returns based on historical experience. Our products are often manufactured to meet the specific design needs of our customers’ applications. Our engineers work closely with customers to ensure that our products will meet their needs. Our customers are under no obligation to compensate us for designing the products we sell.

Contracts with customers

A revenue contract exists once a customer purchase order is received, reviewed and accepted. Prior to accepting a customer purchase order, we review the credit worthiness of the customer. Purchase orders are deemed to meet the collectability criterion once the customer’s credit is approved.

Contract Liabilities: Contract liabilities and revenue recognized were as follows (in thousands):

	May 29, 2021		Additions		Revenue Recognized			February 26, 2022
Contract liabilities (deferred revenue)	$	3,313	$	5,071	$	(3,956	)	$	4,428

The Company receives advance payments or deposits from our customers before revenue is recognized resulting in contract liabilities. Contract liabilities are included in accrued liabilities in the consolidated balance sheets.

Performance obligations and satisfaction of performance obligation in the contract

Each accepted purchase order identifies a distinct good or service as the performance obligation. The goods are generally standard products we purchased from a supplier and stocked on our shelves. They can also be customized products purchased from a supplier or products that are customized or have value added to them in house prior to shipping to the customer. Our contracts for customized products generally include termination provisions if a customer cancels its order. However, we recognize revenue at a point in time because the termination provisions do not require, upon cancelation, the customer to pay fees that are commensurate with the work performed. Each purchase order explicitly states the goods or service that we promise to transfer to the customer. The promises to the customer are limited only to those goods or service. The performance obligation is our promise to deliver both goods

that were produced by the Company and resale of goods that we purchase from our suppliers. Our shipping and handling activities for destination shipments are performed prior to the customer obtaining control. As such, they are not a separate promised service. For shipping point, the Company is making the election under ASC 606-10-25-18B to account for shipping and handling as activities to fulfill the promise to transfer the goods. The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit. The goods are also distinct in that each item sold to the customer is clearly identified on both the purchase order and resulting invoice. Each product we sell benefits the customer independently of the other products. Each item on each purchase order from the customer can be used by the customer unrelated to any other products we provide to the customer.

Determine the transaction price and variable consideration

The transaction price for each product is the amount invoiced to the customer. Each product on a purchase order is a separate performance obligation with an observable standalone selling price. The transaction price is a fixed price per unit, except for the variable consideration. The Company elects to exclude sales tax from the transaction price.

Recognize revenue when the entity satisfies a performance obligation

We recognize revenue at a point in time when title transfers to the customer, at the shipping point for FOB shipping contracts and at the customer’s delivery location for FOB destination contracts. We believe that the transfer of title best represents when the customer obtains control of the goods. Prior to that date, we do not have right to payment, and the significant risks and rewards remain with us. The significant risks and rewards of ownership of the inventory transfer simultaneously with the transfer of title. The customer’s acceptance of the goods is based on objective measurements, not subjective.

Additional considerations

Sale with right of return:

Our return policy is available to customers in our terms and conditions found on our website www.rell.com. The policy varies by business unit. The Company allows returns with prior written authorization and we allow returns within ten days of shipment for replacement parts.  

The Company maintains a reserve for returns based on historical trends that covers all contracts and revenue streams using the expected value method because we have a large number of contracts with similar characteristics, which is considered variable consideration. The reserve for returns creates a refund liability on our balance sheet as a contra Trade Accounts Receivable as well as an asset in inventory. We value the inventory at cost due to there being minimal or no costs to the Company as we generally require the customer to pay freight and we typically do not have costs associated with activities such as relabeling or repackaging.

The reserve is considered immaterial at each balance sheet date for further consideration. Returns for defective product are typically covered by our suppliers’ warranty, thus, returns for defective product are not factored into our reserve.

Warranties:

We offer warranties for the limited number of specific products we manufacture. For further information regarding the impact of warranties see the Warranties discussion elsewhere in Note 3.

Principal versus agent considerations:

Principal versus agent guidance was considered for customized products that are provided by our suppliers versus manufactured by the Company. The Company acts as the principal as we are responsible for satisfying the performance obligation. We have primary responsibility for fulfilling the contract, we have inventory risk prior to delivery to our customer, we establish prices, our consideration is not in the form of a commission and we bear the credit risk. The Company recognizes revenue in the gross amount of consideration.

See Note 7, Segment Reporting, for a disaggregation of revenue by reportable segment and geographic region, which represents how our chief operating decision maker reviews information internally to evaluate our financial performance and to make resource allocation and other decisions for the Company.

Loss Contingencies: We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. If we determine that there is at least a reasonable possibility that a loss may have been incurred, we will include a disclosure describing the contingency.

Intangible Assets: Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. Intangible assets that have finite useful lives are amortized over their useful lives either on a straight-line basis or over their projected future cash flows and are tested for impairment when events or changes in circumstances occur that indicate possible impairment. Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with the acquisitions. Intangible assets subject to amortization were as follows (in thousands):

	February 26, 2022		May 29, 2021
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships(1)		3,410		3,426
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,476	$	4,492
Accumulated Amortization:
Trade Name	$	659	$	659
Customer Relationships		1,409		1,249
Non-compete Agreements		177		177
Technology		154		137
Total Accumulated Amortization	$	2,399	$	2,222
Net Intangible Assets	$	2,077	$	2,270

(1) Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands): 

Fiscal Year	Amortization Expense
Remaining 2022	$	63
2023		246
2024		232
2025		219
2026		185
Thereafter		1,132
Total amortization	$	2,077

The weighted average number of years of amortization expense remaining is 12.2 years.

Income Taxes: We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review our deferred tax assets for recoverability and determine the need for a valuation allowance based on a number of factors, including both positive and negative evidence. These factors include historical taxable income or loss, projected future taxable income or loss, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. In circumstances where we, or any of our affiliates, have incurred three years of cumulative losses which constitute significant negative evidence, positive evidence of equal or greater significance is needed to overcome the negative evidence before a tax benefit is recognized for deductible temporary differences and loss carryforwards.

Accrued Liabilities: Accrued liabilities consisted of the following (in thousands):

	February 26, 2022		May 29, 2021
Compensation and payroll taxes	$	4,740	$	4,945
Accrued severance		678		685
Professional fees		614		533
Deferred revenue		4,428		3,313
Other accrued expenses		5,515		4,706
Accrued Liabilities	$	15,975	$	14,182

Warranties: We offer warranties for the limited number of specific products we manufacture. Our warranty terms generally range from one to three years.

We estimate the cost to perform under the warranty obligation and recognize this estimated cost at the time of the related product sale. We record expense related to our warranty obligations as cost of sales in our consolidated statements of comprehensive income. Each quarter, we assess actual warranty costs incurred on a product-by-product basis and compare the warranty costs to our estimated warranty obligation. With respect to new products, estimates are based generally on knowledge of the products and warranty experience, if a sufficient history exists.

Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. Warranty reserves are included in accrued liabilities on our consolidated balance sheets. The warranty reserves are determined based on known product failures, historical experience and other available evidence. Warranty reserves were approximately $0.7 million as of February 26, 2022 and $0.5 million as of May 29, 2021.

XML

Lease Obligations and Other Commitments

9 Months Ended

Feb. 26, 2022

Commitments And Contingencies Disclosure [Abstract]

Lease Obligations and Other Commitments

4.  LEASE OBLIGATIONS AND OTHER COMMITMENTS

The Company leases real and personal property in the normal course of business under various operating leases and financing leases. The Company has two types of operating leases: leases for facility space and leases for automobiles. Most of the leased facility space is for sales and general office use. Automobile leases are used throughout the Company. The financing lease is for our computer servers.

The gross amounts of assets and liabilities related to both operating and financing leases were as follows (in thousands):

Lease Type	February 26, 2022		May 29, 2021
Operating lease ROU asset	$	3,263	$	2,262
Financing lease ROU asset		239		308
Total lease ROU asset	$	3,502	$	2,570
Operating lease liability current	$	1,149	$	918
Financing lease liability current		15		148
Total lease liability current	$	1,164	$	1,066
Operating lease liability non-current	$	2,113	$	1,358
Total lease liability non-current	$	2,113	$	1,358

The components of lease costs were as follows (in thousands):

		Three Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	452	$	484
Consolidated financing lease amortization	Operating expenses		23		23
Consolidated financing lease interest	Interest expense		1		2
Consolidated financing lease expense			24		25
Net lease cost		$	476	$	509

		Nine Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	1,353	$	1,474
Consolidated financing lease amortization	Operating expenses		69		69
Consolidated financing lease interest	Interest expense		4		9
Consolidated financing lease expense			73		78
Net lease cost		$	1,426	$	1,552

The approximate future minimum lease payments under operating and financing leases at February 26, 2022 were as follows (in thousands):

Fiscal Year	Operating Leases		Financing Leases		Total
Remaining 2022	$	338	$	15	$	353
2023		1,218		—		1,218
2024		838		—		838
2025		586		—		586
2026		401		—		401
Thereafter		94		—		94
Total lease payments		3,475		15		3,490
Less imputed interest		213		—		213
Net minimum lease payments	$	3,262	$	15	$	3,277

The weighted average remaining lease terms and interest rates of leases held by the Company as of February 26, 2022 were as follows:

Lease Type	Weighted Average Remaining Lease Term in Years	Weighted Average Interest Rate
Operating leases	3.4	4.5%
Financing leases	0.1	4.6%

The cash outflows of the leasing activity of the Company as lessee for the nine months ending February 26, 2022 and February 27, 2021 were as follows (in thousands):

		Nine Months Ended
Cash Flow Source	Classification	February 26, 2022		February 27, 2021
Operating cash flows from operating leases	Operating activities	$	986	$	430
Operating cash flows from financing leases	Operating activities		133		127
Finance cash flows from financing leases	Financing activities		136		136

XML

Income Taxes

9 Months Ended

Feb. 26, 2022

Income Tax Disclosure [Abstract]

Income Taxes

5.  INCOME TAXES

We recorded an income tax provision of $1.3 million and $0.2 million for the first nine months of fiscal 2022 and the first nine months of fiscal 2021, respectively. The increase in the tax provision from fiscal 2021 reflects higher foreign taxes, geographical distribution of income (loss) and state income tax provision due to temporary suspension of net operating loss utilization in Illinois and California.

In the normal course of business, we are subject to examination by taxing authorities throughout the world. Generally, years prior to fiscal 2015 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We are currently under examination in Thailand (fiscal 2008 through 2011) and Germany (fiscal 2015 through 2018). Our primary foreign tax jurisdictions are Germany and the Netherlands. We have tax years open in Germany beginning in fiscal 2015 and the Netherlands beginning in fiscal 2018.

We have historically determined that certain undistributed earnings of our foreign subsidiaries, to the extent of cash available, will be repatriated to the U.S. The deferred tax liability on the outside basis difference is now primarily withholding tax on future dividend distributions. We have provided a deferred tax liability of less than $0.1 million as of both February 26, 2022 and as of May 29, 2021.

As of February 26, 2022 and as of May 29, 2021, our worldwide liability for uncertain tax positions related to continuing operations was $0.1 million, excluding interest and penalties. We record penalties and interest related to uncertain tax positions in the income tax expense line item within the consolidated statements of comprehensive income.

The valuation allowance against the net deferred tax assets that will more likely than not be realized was $9.6 million as of February 26, 2022. The valuation allowance against the net deferred tax assets was $12.2 million as of May 29, 2021 and the Company is utilizing prior losses in the first three quarters of fiscal 2022 against its income. A full valuation allowance on the U.S. and state deferred tax assets will be maintained until sufficient positive evidence related to sources of future taxable income exists to support a reversal of the valuation allowance. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are increased, or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as our projections for growth.

XML

Calculation of Earnings Per Share

9 Months Ended

Feb. 26, 2022

Earnings Per Share [Abstract]

Calculation of Earnings Per Share

6.  CALCULATION OF EARNINGS PER SHARE

We have authorized 17,000,000 shares of common stock and 3,000,000 shares of Class B common stock. The Class B common stock has 10 votes per share and has transferability restrictions; however, Class B common stock may be converted into common stock on a share-for-share basis at any time. With respect to dividends and distributions, shares of common stock and Class B common stock rank equally and have the same rights, except that Class B common stock cash dividends are limited to 90% of the amount of common stock cash dividends.

Our Class B common stock is considered a participating security requiring the use of the two-class method for the computation of basic and diluted earnings per share. The two-class computation method for each period reflects the cash dividends paid per share for each class of stock, plus the amount of allocated undistributed earnings per share computed using the participation percentage which reflects the dividend rights of each class of stock. Basic and diluted earnings per share were computed using the two-class method. The shares of Class B common stock are considered to be participating convertible securities since the shares of Class B common stock are convertible on a share-for-share basis into shares of common stock and may participate in dividends with common stock according to a predetermined formula which is 90% of the amount of common stock cash dividends.

The earnings per share (“EPS”) presented in our unaudited consolidated statements of comprehensive income were based on the following amounts (in thousands, except per share amounts):

	Three Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income	$	2,887	$	2,887	$	228		$	228
Less dividends:
Common stock		695		695		667			667
Class B common stock		111		111		113			113
Undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Common stock undistributed earnings (loss)	$	1,790	$	1,801	$	(472	)	$	(472	)
Class B common stock undistributed earnings (loss)		291		280		(80	)		(80	)
Total undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,497		11,497		11,111			11,111
Effect of dilutive securities
Dilutive stock options				530					72
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				12,027					11,183
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,074		2,074		2,097			2,097
Net income per share:
Common stock	$	0.22	$	0.21	$	0.02		$	0.02
Class B common stock	$	0.19	$	0.19	$	0.02		$	0.02

Note: There were no common stock options that were antidilutive in the third quarter of fiscal 2022 and fiscal 2021.

	Nine Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income (loss)	$	9,644	$	9,644	$	(230	)	$	(230	)
Less dividends:
Common stock		2,047		2,047		2,000			2,000
Class B common stock		337		337		340			340
Undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Common stock undistributed earnings (loss)	$	6,226	$	6,257	$	(2,196	)	$	(2,196	)
Class B common stock undistributed earnings (loss)		1,034		1,003		(374	)		(374	)
Total undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,320		11,320		11,097			11,097
Effect of dilutive securities
Dilutive stock options				404					—
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				11,724					11,097
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,089		2,089		2,097			2,097
Net income (loss) per share:
Common stock	$	0.73	$	0.71	$	(0.02	)	$	(0.02	)
Class B common stock	$	0.66	$	0.64	$	(0.02	)	$	(0.02	)

Note: There were no common stock options that were antidilutive in the first nine months of fiscal 2022. Common stock options that were anti-dilutive and not included in the diluted earnings per common share for the first nine months of fiscal 2021 were 1,300.

XML

Segment Reporting

9 Months Ended

Feb. 26, 2022

Segment Reporting [Abstract]

Segment Reporting

7.  SEGMENT REPORTING

We have identified three reportable segments as follows:

PMT combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies. As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure. PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.

Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets. Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers. We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, All-In-One computers, specialized cabinet finishes and application specific software packages and certification services. We partner with both private label manufacturing companies and leading branded hardware vendors to offer the highest quality display and touch solutions and customized computing platforms.

Healthcare manufactures, repairs, refurbishes and distributes high value replacement parts and equipment for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers. Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market. Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency while lowering the cost of healthcare delivery.

The CEO, who is the chief operating decision maker, evaluates performance and allocates resources primarily based on the gross profit of each segment.

Operating results by segment are summarized in the following table (in thousands):

	Three Months Ended				Nine Months Ended
	February 26, 2022		February 27, 2021		February 26, 2022		February 27, 2021
PMT
Net Sales	$	44,032	$	35,237	$	128,778	$	98,418
Gross Profit		14,163		12,308		41,080		33,530
Canvys
Net Sales		8,141		7,078		25,732		20,491
Gross Profit		2,618		2,493		8,348		7,156
Healthcare
Net Sales		3,135		2,920		8,481		7,556
Gross Profit		788		965		2,095		1,782

Geographic net sales information is primarily grouped by customer destination into five areas: North America; Asia/Pacific; Europe; Latin America; and Other.

Net sales and gross profit by geographic region are summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Net Sales
North America	$	23,647		$	19,654		$	68,615		$	53,513
Asia/Pacific		13,275			9,821			38,220			28,970
Europe		16,067			13,285			48,231			37,277
Latin America		2,380			2,446			7,976			6,591
Other (1)		(61	)		29			(51	)		114
Total	$	55,308		$	45,235		$	162,991		$	126,465
Gross Profit
North America	$	8,946		$	8,081		$	24,984		$	21,099
Asia/Pacific		4,061			3,517			12,126			9,592
Europe		4,884			4,356			14,507			12,153
Latin America		917			896			2,998			2,345
Other (1)		(1,239	)		(1,084	)		(3,092	)		(2,721	)
Total	$	17,569		$	15,766		$	51,523		$	42,468

(1) Other includes primarily net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.

We sell our products to customers in diversified industries and perform periodic credit evaluations of our customers’ financial condition. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America. Estimates of credit losses are recorded in the financial statements based on monthly reviews of outstanding accounts.

XML

Risks and Uncertainties

9 Months Ended

Feb. 26, 2022

Risks And Uncertainties [Abstract]

Risks and Uncertainties

8. RISKS AND UNCERTAINTIES

Company Response to COVID-19

In March 2020, the World Health Organization classified the outbreak of COVID-19 as a pandemic. Thereafter, most U.S. states imposed “shelter in place” or similar directives on their populations to stem the spread of COVID-19 and similar restrictive

measures were taken by governments across the world. Throughout the duration of such restrictions, the Company was considered a critical supplier of products to healthcare and critical infrastructure businesses and, accordingly, the Company continued our manufacturing and distribution operations as an “essential business” throughout the implementation of various restrictions on operations in our fiscal 2021 and beyond. Our top priority was ensuring the health and safety of our employees and, accordingly, we undertook measures such as limiting the number of people in any one of our facilities by requiring only employees who could not perform their work remotely to physically work in a Company US-based facility. The Company advised all other employees that could perform their job functions remotely to do so. As such, the Company’s operations have remained operational during the pandemic.

The impact of the COVID-19 outbreak and its effects continue to evolve. As such, the full magnitude that the pandemic, its effects, and the steps taken to prevent and/or mitigate its spread or otherwise address its impact, will have on the Company’s financial condition, liquidity and future results of operations is uncertain. The extent of the impact of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the duration and spread of the pandemic, the extent, speed and effectiveness of worldwide containment and vaccination effort, any subsequent wave or waves of outbreaks, and the impact of these and other factors on our employees, customers and suppliers. Our ability to meet customer demands for products may be impaired or, similarly, our customers may experience adverse business consequences due to COVID-19 and its effects. Reduced demand for products or impaired ability to meet customer demand (including disruptions at our transportation service providers or vendors or otherwise in our supply chain) could have a material adverse effect on our business, operations and financial performance. While we had some COVID-19 related component delays impacting new product development schedules, we did not experience a major interruption in our supply chain. Management continues to monitor the global situation on its financial condition, liquidity, operations, suppliers, industry and workforce. Given the ever-evolving nature of the pandemic and the continued global responses to curb its spread, the Company is not presently able to fully estimate the effects of COVID-19 on its results of operations, financial condition or liquidity for fiscal year 2022.

Company Response to CARES Act

On March 27, 2020, Congress enacted the Coronavirus Aid, Relief and Economic Security (“CARES”) Act to provide certain relief as a result of the COVID-19 outbreak. The CARES Act included provisions relating to refundable payroll tax credits, deferral of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, increased limitations on qualified charitable contributions and technical corrections to tax depreciation methods for qualified, improvement property. As of February 26, 2022, the Company deferred $0.5 million of employer-side social security tax payments. The Company has estimated and recorded the overall effects of the CARES Act and does not anticipate a material change.

XML

Fair Value Measurements

9 Months Ended

Feb. 26, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

9. FAIR VALUE MEASUREMENTS

Investments are measured at fair value. The Company had no investments as of February 26, 2022 and May 29, 2021.

XML

Related Party Transaction

9 Months Ended

Feb. 26, 2022

Related Party Transactions [Abstract]

Related Party Transaction

10. RELATED PARTY TRANSACTION

On June 15, 2015, the Company entered into a lease agreement for the IMES facility with LDL, LLC. That lease agreement was extended for five years in fiscal 2021. The Company shall be entitled to extend the term of the lease for a period of an additional five years by notifying the landlord in writing of its intention to do so within six months of the expiration of the term. The Executive Vice President of IMES, Lee A. McIntyre III (former owner of IMES), has an ownership interest in LDL, LLC. The lease agreement provides for monthly payments over five years with total future minimum lease payments of $0.5 million. Rental expense related to this lease amounted to $0.1 million for the nine months ended February 26, 2022 and February 27, 2021.

XML

Critical Accounting Policies and Estimates (Policies)

9 Months Ended

Feb. 26, 2022

Accounting Policies [Abstract]

Inventories, net

Inventories, net: Our consolidated inventories were stated at the lower of cost and net realizable value, generally using a weighted-average cost method. Our net inventories include approximately $62.1 million of finished goods, $7.0 million of raw materials and $4.6 million of work-in-progress as of February 26, 2022, as compared to approximately $57.0 million of finished goods, $3.9 million of raw materials and $2.6 million of work-in-progress as of May 29, 2021.

At this time, we do not anticipate any material risks or uncertainties related to possible future inventory write-downs. Provisions for obsolete or slow-moving inventories are recorded based upon regular analysis of stock rotation privileges, obsolescence, the exiting of certain markets and assumptions about future demand and market conditions. If future demand changes in the industry, or market conditions differ from management’s estimates, additional provisions may be necessary. Inventory reserves were approximately $5.9 million as of February 26, 2022 and $5.9 million as of May 29, 2021.

Revenue Recognition

Revenue Recognition: The Company’s revenue streams include distribution, manufacturing and service revenue. The distribution business does not include a separate service bundled with the product sold or sold on top of the product. Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers. Revenue is recognized when control of the promised goods is transferred to our customers, which is simultaneous with the title transferring to the customer, in an amount that reflects the transaction price consideration that we expect to receive in exchange for those goods. Control refers to the ability of the customer to direct the use of, and obtain substantially all of, the remaining benefits from the goods. Our transaction price consideration is fixed, unless otherwise disclosed below as variable consideration. Generally, our contracts require our customers to pay for goods after we deliver products to them. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America subject to customary credit checks.

The Company also sells products that are manufactured or assembled in our manufacturing facility. These products can either be built to the customer’s prints/designs or are products that we stock in our warehouse to sell to any customer that places an order. The manufacturing business does not include a separate service bundled with the product sold or sold in addition to the product.

The Company recognizes services revenue when the repair, installation or training is performed. The services we provide are relatively short in duration and typically completed in one or two weeks. Therefore, at each reporting date, the amount of unbilled work is insignificant. The services revenue has consistently accounted for less than 5% of the Company’s total revenues and is expected to continue at that level.

We also record discounts taken and estimate returns based on historical experience. Our products are often manufactured to meet the specific design needs of our customers’ applications. Our engineers work closely with customers to ensure that our products will meet their needs. Our customers are under no obligation to compensate us for designing the products we sell.

Contracts with customers

A revenue contract exists once a customer purchase order is received, reviewed and accepted. Prior to accepting a customer purchase order, we review the credit worthiness of the customer. Purchase orders are deemed to meet the collectability criterion once the customer’s credit is approved.

Contract Liabilities: Contract liabilities and revenue recognized were as follows (in thousands):

	May 29, 2021		Additions		Revenue Recognized			February 26, 2022
Contract liabilities (deferred revenue)	$	3,313	$	5,071	$	(3,956	)	$	4,428

The Company receives advance payments or deposits from our customers before revenue is recognized resulting in contract liabilities. Contract liabilities are included in accrued liabilities in the consolidated balance sheets.

Performance obligations and satisfaction of performance obligation in the contract

Each accepted purchase order identifies a distinct good or service as the performance obligation. The goods are generally standard products we purchased from a supplier and stocked on our shelves. They can also be customized products purchased from a supplier or products that are customized or have value added to them in house prior to shipping to the customer. Our contracts for customized products generally include termination provisions if a customer cancels its order. However, we recognize revenue at a point in time because the termination provisions do not require, upon cancelation, the customer to pay fees that are commensurate with the work performed. Each purchase order explicitly states the goods or service that we promise to transfer to the customer. The promises to the customer are limited only to those goods or service. The performance obligation is our promise to deliver both goods

that were produced by the Company and resale of goods that we purchase from our suppliers. Our shipping and handling activities for destination shipments are performed prior to the customer obtaining control. As such, they are not a separate promised service. For shipping point, the Company is making the election under ASC 606-10-25-18B to account for shipping and handling as activities to fulfill the promise to transfer the goods. The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit. The goods are also distinct in that each item sold to the customer is clearly identified on both the purchase order and resulting invoice. Each product we sell benefits the customer independently of the other products. Each item on each purchase order from the customer can be used by the customer unrelated to any other products we provide to the customer.

Determine the transaction price and variable consideration

The transaction price for each product is the amount invoiced to the customer. Each product on a purchase order is a separate performance obligation with an observable standalone selling price. The transaction price is a fixed price per unit, except for the variable consideration. The Company elects to exclude sales tax from the transaction price.

Recognize revenue when the entity satisfies a performance obligation

We recognize revenue at a point in time when title transfers to the customer, at the shipping point for FOB shipping contracts and at the customer’s delivery location for FOB destination contracts. We believe that the transfer of title best represents when the customer obtains control of the goods. Prior to that date, we do not have right to payment, and the significant risks and rewards remain with us. The significant risks and rewards of ownership of the inventory transfer simultaneously with the transfer of title. The customer’s acceptance of the goods is based on objective measurements, not subjective.

Additional considerations

Sale with right of return:

Our return policy is available to customers in our terms and conditions found on our website www.rell.com. The policy varies by business unit. The Company allows returns with prior written authorization and we allow returns within ten days of shipment for replacement parts.  

The Company maintains a reserve for returns based on historical trends that covers all contracts and revenue streams using the expected value method because we have a large number of contracts with similar characteristics, which is considered variable consideration. The reserve for returns creates a refund liability on our balance sheet as a contra Trade Accounts Receivable as well as an asset in inventory. We value the inventory at cost due to there being minimal or no costs to the Company as we generally require the customer to pay freight and we typically do not have costs associated with activities such as relabeling or repackaging.

The reserve is considered immaterial at each balance sheet date for further consideration. Returns for defective product are typically covered by our suppliers’ warranty, thus, returns for defective product are not factored into our reserve.

Warranties:

We offer warranties for the limited number of specific products we manufacture. For further information regarding the impact of warranties see the Warranties discussion elsewhere in Note 3.

Principal versus agent considerations:

Principal versus agent guidance was considered for customized products that are provided by our suppliers versus manufactured by the Company. The Company acts as the principal as we are responsible for satisfying the performance obligation. We have primary responsibility for fulfilling the contract, we have inventory risk prior to delivery to our customer, we establish prices, our consideration is not in the form of a commission and we bear the credit risk. The Company recognizes revenue in the gross amount of consideration.

See Note 7, Segment Reporting, for a disaggregation of revenue by reportable segment and geographic region, which represents how our chief operating decision maker reviews information internally to evaluate our financial performance and to make resource allocation and other decisions for the Company.

Loss Contingencies

Loss Contingencies: We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. If we determine that there is at least a reasonable possibility that a loss may have been incurred, we will include a disclosure describing the contingency.

Intangible Assets

Intangible Assets: Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. Intangible assets that have finite useful lives are amortized over their useful lives either on a straight-line basis or over their projected future cash flows and are tested for impairment when events or changes in circumstances occur that indicate possible impairment. Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with the acquisitions. Intangible assets subject to amortization were as follows (in thousands):

	February 26, 2022		May 29, 2021
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships(1)		3,410		3,426
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,476	$	4,492
Accumulated Amortization:
Trade Name	$	659	$	659
Customer Relationships		1,409		1,249
Non-compete Agreements		177		177
Technology		154		137
Total Accumulated Amortization	$	2,399	$	2,222
Net Intangible Assets	$	2,077	$	2,270

(1) Change from prior periods reflect impact of foreign currency translation.

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands): 

Fiscal Year	Amortization Expense
Remaining 2022	$	63
2023		246
2024		232
2025		219
2026		185
Thereafter		1,132
Total amortization	$	2,077

The weighted average number of years of amortization expense remaining is 12.2 years.

Income Taxes

Income Taxes: We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review our deferred tax assets for recoverability and determine the need for a valuation allowance based on a number of factors, including both positive and negative evidence. These factors include historical taxable income or loss, projected future taxable income or loss, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. In circumstances where we, or any of our affiliates, have incurred three years of cumulative losses which constitute significant negative evidence, positive evidence of equal or greater significance is needed to overcome the negative evidence before a tax benefit is recognized for deductible temporary differences and loss carryforwards.

Accrued Liabilities

Accrued Liabilities: Accrued liabilities consisted of the following (in thousands):

	February 26, 2022		May 29, 2021
Compensation and payroll taxes	$	4,740	$	4,945
Accrued severance		678		685
Professional fees		614		533
Deferred revenue		4,428		3,313
Other accrued expenses		5,515		4,706
Accrued Liabilities	$	15,975	$	14,182

Warranties

Warranties: We offer warranties for the limited number of specific products we manufacture. Our warranty terms generally range from one to three years.

We estimate the cost to perform under the warranty obligation and recognize this estimated cost at the time of the related product sale. We record expense related to our warranty obligations as cost of sales in our consolidated statements of comprehensive income. Each quarter, we assess actual warranty costs incurred on a product-by-product basis and compare the warranty costs to our estimated warranty obligation. With respect to new products, estimates are based generally on knowledge of the products and warranty experience, if a sufficient history exists.

Warranty reserves are established for costs that are expected to be incurred after the sale and delivery of products under warranty. Warranty reserves are included in accrued liabilities on our consolidated balance sheets. The warranty reserves are determined based on known product failures, historical experience and other available evidence. Warranty reserves were approximately $0.7 million as of February 26, 2022 and $0.5 million as of May 29, 2021.

XML

Critical Accounting Policies and Estimates (Tables)

9 Months Ended

Feb. 26, 2022

Accounting Policies [Abstract]

Schedule of Contract Liabilities and Revenue Recognized

Contract Liabilities: Contract liabilities and revenue recognized were as follows (in thousands):

	May 29, 2021		Additions		Revenue Recognized			February 26, 2022
Contract liabilities (deferred revenue)	$	3,313	$	5,071	$	(3,956	)	$	4,428

Schedule of Intangible Assets Subject to Amortization

Intangible assets subject to amortization were as follows

	February 26, 2022		May 29, 2021
Gross Amounts:
Trade Name	$	659	$	659
Customer Relationships(1)		3,410		3,426
Non-compete Agreements		177		177
Technology		230		230
Total Gross Amounts	$	4,476	$	4,492
Accumulated Amortization:
Trade Name	$	659	$	659
Customer Relationships		1,409		1,249
Non-compete Agreements		177		177
Technology		154		137
Total Accumulated Amortization	$	2,399	$	2,222
Net Intangible Assets	$	2,077	$	2,270

(1) Change from prior periods reflect impact of foreign currency translation.

Schedule of the Amortization Expense for the Next Five Years

The amortization expense associated with the intangible assets subject to amortization for the next five years is presented in the following table (in thousands): 

Fiscal Year	Amortization Expense
Remaining 2022	$	63
2023		246
2024		232
2025		219
2026		185
Thereafter		1,132
Total amortization	$	2,077

Schedule of Accrued Liabilities

Accrued Liabilities: Accrued liabilities consisted of the following (in thousands):

	February 26, 2022		May 29, 2021
Compensation and payroll taxes	$	4,740	$	4,945
Accrued severance		678		685
Professional fees		614		533
Deferred revenue		4,428		3,313
Other accrued expenses		5,515		4,706
Accrued Liabilities	$	15,975	$	14,182

XML

Lease Obligations and Other Commitments (Tables)

9 Months Ended

Feb. 26, 2022

Commitments And Contingencies Disclosure [Abstract]

Schedule of Gross Amount Assets and Liabilities Related to Operating and Financing Leases

The gross amounts of assets and liabilities related to both operating and financing leases were as follows (in thousands):

Lease Type	February 26, 2022		May 29, 2021
Operating lease ROU asset	$	3,263	$	2,262
Financing lease ROU asset		239		308
Total lease ROU asset	$	3,502	$	2,570
Operating lease liability current	$	1,149	$	918
Financing lease liability current		15		148
Total lease liability current	$	1,164	$	1,066
Operating lease liability non-current	$	2,113	$	1,358
Total lease liability non-current	$	2,113	$	1,358

Components of Lease Costs

The components of lease costs were as follows (in thousands):

		Three Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	452	$	484
Consolidated financing lease amortization	Operating expenses		23		23
Consolidated financing lease interest	Interest expense		1		2
Consolidated financing lease expense			24		25
Net lease cost		$	476	$	509

		Nine Months Ended
		February 26, 2022		February 27, 2021
Consolidated operating lease expense	Operating expenses	$	1,353	$	1,474
Consolidated financing lease amortization	Operating expenses		69		69
Consolidated financing lease interest	Interest expense		4		9
Consolidated financing lease expense			73		78
Net lease cost		$	1,426	$	1,552

Schedule of Future Minimum Lease Payments under Operating and Financing Leases

The approximate future minimum lease payments under operating and financing leases at February 26, 2022 were as follows (in thousands):

Fiscal Year	Operating Leases		Financing Leases		Total
Remaining 2022	$	338	$	15	$	353
2023		1,218		—		1,218
2024		838		—		838
2025		586		—		586
2026		401		—		401
Thereafter		94		—		94
Total lease payments		3,475		15		3,490
Less imputed interest		213		—		213
Net minimum lease payments	$	3,262	$	15	$	3,277

Schedule of Weighted Average Remaining Lease Terms and Interest Rates of Leases

The weighted average remaining lease terms and interest rates of leases held by the Company as of February 26, 2022 were as follows:

Lease Type	Weighted Average Remaining Lease Term in Years	Weighted Average Interest Rate
Operating leases	3.4	4.5%
Financing leases	0.1	4.6%

Schedule of Cash Outflows of Leasing Activity

The cash outflows of the leasing activity of the Company as lessee for the nine months ending February 26, 2022 and February 27, 2021 were as follows (in thousands):

		Nine Months Ended
Cash Flow Source	Classification	February 26, 2022		February 27, 2021
Operating cash flows from operating leases	Operating activities	$	986	$	430
Operating cash flows from financing leases	Operating activities		133		127
Finance cash flows from financing leases	Financing activities		136		136

XML

Calculation of Earnings Per Share (Tables)

9 Months Ended

Feb. 26, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The earnings per share (“EPS”) presented in our unaudited consolidated statements of comprehensive income were based on the following amounts (in thousands, except per share amounts):

	Three Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income	$	2,887	$	2,887	$	228		$	228
Less dividends:
Common stock		695		695		667			667
Class B common stock		111		111		113			113
Undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Common stock undistributed earnings (loss)	$	1,790	$	1,801	$	(472	)	$	(472	)
Class B common stock undistributed earnings (loss)		291		280		(80	)		(80	)
Total undistributed earnings (loss)	$	2,081	$	2,081	$	(552	)	$	(552	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,497		11,497		11,111			11,111
Effect of dilutive securities
Dilutive stock options				530					72
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				12,027					11,183
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,074		2,074		2,097			2,097
Net income per share:
Common stock	$	0.22	$	0.21	$	0.02		$	0.02
Class B common stock	$	0.19	$	0.19	$	0.02		$	0.02

Note: There were no common stock options that were antidilutive in the third quarter of fiscal 2022 and fiscal 2021.

	Nine Months Ended
	February 26, 2022				February 27, 2021
	Basic		Diluted		Basic			Diluted
Numerator for Basic and Diluted EPS:
Net income (loss)	$	9,644	$	9,644	$	(230	)	$	(230	)
Less dividends:
Common stock		2,047		2,047		2,000			2,000
Class B common stock		337		337		340			340
Undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Common stock undistributed earnings (loss)	$	6,226	$	6,257	$	(2,196	)	$	(2,196	)
Class B common stock undistributed earnings (loss)		1,034		1,003		(374	)		(374	)
Total undistributed earnings (loss)	$	7,260	$	7,260	$	(2,570	)	$	(2,570	)
Denominator for Basic and Diluted EPS:
Common stock weighted average shares		11,320		11,320		11,097			11,097
Effect of dilutive securities
Dilutive stock options				404					—
Denominator for diluted EPS adjusted for weighted average shares and assumed conversion				11,724					11,097
Class B commons stock weighted average shares and shares under if-converted method for diluted EPS		2,089		2,089		2,097			2,097
Net income (loss) per share:
Common stock	$	0.73	$	0.71	$	(0.02	)	$	(0.02	)
Class B common stock	$	0.66	$	0.64	$	(0.02	)	$	(0.02	)

Note: There were no common stock options that were antidilutive in the first nine months of fiscal 2022. Common stock options that were anti-dilutive and not included in the diluted earnings per common share for the first nine months of fiscal 2021 were 1,300.

XML

Segment Reporting (Tables)

9 Months Ended

Feb. 26, 2022

Segment Reporting [Abstract]

Schedule of Operating Results by Segment

Operating results by segment are summarized in the following table (in thousands):

	Three Months Ended				Nine Months Ended
	February 26, 2022		February 27, 2021		February 26, 2022		February 27, 2021
PMT
Net Sales	$	44,032	$	35,237	$	128,778	$	98,418
Gross Profit		14,163		12,308		41,080		33,530
Canvys
Net Sales		8,141		7,078		25,732		20,491
Gross Profit		2,618		2,493		8,348		7,156
Healthcare
Net Sales		3,135		2,920		8,481		7,556
Gross Profit		788		965		2,095		1,782

Schedule of Net Sales and Gross Profit by Geographic Region

Net sales and gross profit by geographic region are summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	February 26, 2022			February 27, 2021			February 26, 2022			February 27, 2021
Net Sales
North America	$	23,647		$	19,654		$	68,615		$	53,513
Asia/Pacific		13,275			9,821			38,220			28,970
Europe		16,067			13,285			48,231			37,277
Latin America		2,380			2,446			7,976			6,591
Other (1)		(61	)		29			(51	)		114
Total	$	55,308		$	45,235		$	162,991		$	126,465
Gross Profit
North America	$	8,946		$	8,081		$	24,984		$	21,099
Asia/Pacific		4,061			3,517			12,126			9,592
Europe		4,884			4,356			14,507			12,153
Latin America		917			896			2,998			2,345
Other (1)		(1,239	)		(1,084	)		(3,092	)		(2,721	)
Total	$	17,569		$	15,766		$	51,523		$	42,468

(1) Other includes primarily net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.

XML

Description of the Company - Additional Information (Details)	9 Months Ended
	Feb. 26, 2022 Segment
Concentration Risk [Line Items]
Number of operating segments	3
Number of reportable segments	3
Minimum | Product Concentration | Sales
Concentration Risk [Line Items]
Percentage of products manufactured	60.00%

XML

Critical Accounting Policies and Estimates - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Feb. 26, 2022	May 29, 2021
Critical Accounting Policies And Estimates [Line Items]
Finished goods	$ 62.1	$ 57.0
Raw material	7.0	3.9
Work in progress	4.6	2.6
Inventory valuation reserves	$ 5.9	5.9
Weighted average number of years of amortization expense	12 years 2 months 12 days
Warranty reserves	$ 0.7	$ 0.5
Maximum
Critical Accounting Policies And Estimates [Line Items]
Services revenue recognized as percentage of aggregate revenue	5.00%
Warranty term	3 years
Minimum
Critical Accounting Policies And Estimates [Line Items]
Warranty term	1 year

XML

Critical Accounting Policies and Estimates - Schedule of Contract Liabilities and Revenue Recognized (Details) $ in Thousands	9 Months Ended
	Feb. 26, 2022 USD ($)
Revenue From Contract With Customer [Abstract]
Contract Liabilities (Deferred Revenue), Beginning Balance	$ 3,313
Contract Liabilities (Deferred Revenue), Additions	5,071
Contract Liabilities (Deferred Revenue), Revenue Recognized	(3,956)
Contract Liabilities (Deferred Revenue), Ending Balance	$ 4,428

XML

Critical Accounting Policies and Estimates - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($) $ in Thousands		Feb. 26, 2022	May 29, 2021
Finite-Lived Intangible Assets [Line Items]
Total Gross Amounts		$ 4,476	$ 4,492
Total Accumulated Amortization		2,399	2,222
Net Intangible Assets		2,077	2,270
Trade Names
Finite-Lived Intangible Assets [Line Items]
Total Gross Amounts		659	659
Total Accumulated Amortization		659	659
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Total Gross Amounts	[1]	3,410	3,426
Total Accumulated Amortization		1,409	1,249
Non-compete Agreements
Finite-Lived Intangible Assets [Line Items]
Total Gross Amounts		177	177
Total Accumulated Amortization		177	177
Technology
Finite-Lived Intangible Assets [Line Items]
Total Gross Amounts		230	230
Total Accumulated Amortization		$ 154	$ 137

[1] Change from prior periods reflect impact of foreign currency translation.

XML

Critical Accounting Policies and Estimates - Schedule of the Amortization Expense for the Next Five Years (Details) - USD ($) $ in Thousands	Feb. 26, 2022	May 29, 2021
Fiscal Year
Remaining 2022	$ 63
2023	246
2024	232
2025	219
2026	185
Thereafter	1,132
Net Intangible Assets	$ 2,077	$ 2,270

XML

Critical Accounting Policies and Estimates - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Feb. 26, 2022	May 29, 2021
Accrued Liabilities:
Compensation and payroll taxes	$ 4,740	$ 4,945
Accrued severance	678	685
Professional fees	614	533
Deferred revenue	4,428	3,313
Other accrued expenses	5,515	4,706
Accrued Liabilities	$ 15,975	$ 14,182

XML

Lease Obligations and Other Commitments - Schedule of Gross Amount Assets and Liabilities Related to Operating and Financing Leases (Details) - USD ($) $ in Thousands	Feb. 26, 2022	May 29, 2021
Lease Type
Operating lease ROU asset	$ 3,263	$ 2,262
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Assets Noncurrent	Assets Noncurrent
Financing lease ROU asset	$ 239	$ 308
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Assets Noncurrent	Assets Noncurrent
Total lease ROU asset	$ 3,502	$ 2,570
Operating lease liability current	$ 1,149	$ 918
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Liabilities Current	Liabilities Current
Financing lease liability current	$ 15	$ 148
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Liabilities Current	Liabilities Current
Total lease liability current	$ 1,164	$ 1,066
Operating lease liability non-current	$ 2,113	$ 1,358
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities
Total lease liability non-current	$ 2,113	$ 1,358

XML

Lease Obligations and Other Commitments - Components of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021
Lease Cost [Abstract]
Consolidated operating lease expense	$ 452	$ 484	$ 1,353	$ 1,474
Consolidated financing lease amortization	23	23	69	69
Consolidated financing lease interest	1	2	4	9
Consolidated financing lease expense	24	25	73	78
Net lease cost	$ 476	$ 509	$ 1,426	$ 1,552

XML

Lease Obligations and Other Commitments - Schedule of Future Minimum Lease Payments Under Operating and Financing Leases (Details) $ in Thousands	Feb. 26, 2022 USD ($)
Operating Leases
Remaining 2022	$ 338
2023	1,218
2024	838
2025	586
2026	401
Thereafter	94
Total lease payments	3,475
Less imputed interest	213
Net minimum lease payments	3,262
Finance Leases
Remaining 2022	15
Total lease payments	15
Net minimum lease payments	15
Total
Remaining 2022	353
2023	1,218
2024	838
2025	586
2026	401
Thereafter	94
Total lease payments	3,490
Less imputed interest	213
Net minimum lease payments	$ 3,277

XML

Lease Obligations and Other Commitments - Schedule of Weighted Average Lease Terms and Interest Rates of Leases (Details)	Feb. 26, 2022
Commitments And Contingencies Disclosure [Abstract]
Weighted average remaining lease term in years, operating leases	3 years 4 months 24 days
Weighted average remaining lease term in years, financing leases	1 month 6 days
Weighted average interest rate, operating leases	4.50%
Weighted average interest rate, financing leases	4.60%

XML

Lease Obligations and Other Commitments - Schedule of Cash Outflows of Leasing Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021
Commitments And Contingencies Disclosure [Abstract]
Operating cash flows from operating leases			$ 986	$ 430
Operating cash flows from financing leases			133	127
Finance cash flows from financing leases	$ 45	$ 45	$ 136	$ 136

XML

Income Taxes - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 27, 2021	May 29, 2021
Operating Loss Carryforwards [Line Items]
Income tax provision	$ 609,000	$ 62,000	$ 1,326,000	$ 239,000
Liability for uncertain tax positions related to continuing operations, excluding interest and penalties	100,000		100,000		$ 100,000
Deferred tax valuation allowance	9,600,000		9,600,000		12,200,000
Maximum
Operating Loss Carryforwards [Line Items]
Deferred tax liability, undistributed earnings of foreign subsidiaries	$ 100,000		$ 100,000		$ 100,000

XML

Calculation of Earnings Per Share - Additional Information (Details)	3 Months Ended		9 Months Ended
	Feb. 26, 2022 shares	Feb. 27, 2021 shares	Feb. 26, 2022 Vote shares	Feb. 27, 2021 shares
Schedule Of Earning Per Share [Line Items]
Limit of cash dividends Class B common stock (percent)			90.00%
Common stock options anti-dilutive	0	0	0	1,300,000
Common Stock
Schedule Of Earning Per Share [Line Items]
Common stock shares, authorized	17,000,000		17,000,000
Common Class B
Schedule Of Earning Per Share [Line Items]
Common stock shares, authorized	3,000,000		3,000,000
Number of votes per share | Vote			10

XML

Calculation of Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Feb. 26, 2022	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 26, 2022	Feb. 27, 2021	Feb. 27, 2021
Numerator for Basic and Diluted Earnings Per Share:
Net income (loss)	$ 2,887	$ 2,887	$ 228		$ 9,644		$ (230)
Undistributed earnings (loss), Basic		2,081	(552)	$ 7,260		$ (2,570)
Undistributed earnings (loss), Diluted		$ 2,081	$ (552)	$ 7,260		$ (2,570)
Denominator for Basic and Diluted Earnings Per Share:
Effect of dilutive securities dilutive stock options		530	72	404
Weighted Average Number of Shares Outstanding, Diluted		12,027	11,183	11,724		11,097
Basic
Numerator for Basic and Diluted Earnings Per Share:
Net income (loss)		$ 2,887	$ 228	$ 9,644		$ (230)
Diluted
Numerator for Basic and Diluted Earnings Per Share:
Net income (loss)		2,887	228	9,644		(230)
Common Stock
Numerator for Basic and Diluted Earnings Per Share:
Undistributed earnings (loss), Basic		1,790	(472)	6,226		(2,196)
Undistributed earnings (loss), Diluted		$ 1,801	$ (472)	$ 6,257		$ (2,196)
Denominator for Basic and Diluted Earnings Per Share:
Weighted Average Number of Shares Outstanding, Basic		11,497	11,111	11,320	11,320	11,097	11,097
Weighted Average Number of Shares Outstanding, Diluted		12,027	11,183		11,724		11,097
Net income (loss) per share:
Earnings Per Share, Basic		$ 0.22	$ 0.02	$ 0.73	$ 0.73	$ (0.02)	$ (0.02)
Earnings Per Share, Diluted		$ 0.21	$ 0.02	$ 0.71	$ 0.71	$ (0.02)	$ (0.02)
Common Stock | Basic
Numerator for Basic and Diluted Earnings Per Share:
Less dividends		$ 695	$ 667	$ 2,047		$ 2,000
Common Stock | Diluted
Numerator for Basic and Diluted Earnings Per Share:
Less dividends		695	667	2,047		2,000
Common Class B
Numerator for Basic and Diluted Earnings Per Share:
Undistributed earnings (loss), Basic		291	(80)	1,034		(374)
Undistributed earnings (loss), Diluted		$ 280	$ (80)	$ 1,003		$ (374)
Denominator for Basic and Diluted Earnings Per Share:
Weighted Average Number of Shares Outstanding, Basic		2,074	2,097	2,089	2,089	2,097	2,097
Weighted Average Number of Shares Outstanding, Diluted		2,074	2,097		2,089		2,097
Net income (loss) per share:
Earnings Per Share, Basic		$ 0.19	$ 0.02	$ 0.66	$ 0.66	$ (0.02)	$ (0.02)
Earnings Per Share, Diluted		$ 0.19	$ 0.02	$ 0.64	$ 0.64	$ (0.02)	$ (0.02)
Common Class B | Basic
Numerator for Basic and Diluted Earnings Per Share:
Less dividends		$ 111	$ 113	$ 337		$ 340
Common Class B | Diluted
Numerator for Basic and Diluted Earnings Per Share:
Less dividends		$ 111	$ 113	$ 337		$ 340

XML

Segment Reporting - Additional Information (Details)	9 Months Ended
	Feb. 26, 2022 Segment
Segment Reporting [Abstract]
Number of reportable segments	3

XML

Segment Reporting - Schedule of Operating Results by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 26, 2022	Feb. 27, 2021	Feb. 27, 2021
Segment Reporting Information [Line Items]
Net Sales	$ 55,308	$ 45,235	$ 162,991	$ 162,991	$ 126,465	$ 126,465
Gross Profit	17,569	15,766	51,523	$ 51,523	42,468	$ 42,468
PMT
Segment Reporting Information [Line Items]
Net Sales	44,032	35,237	128,778		98,418
Gross Profit	14,163	12,308	41,080		33,530
Canvys
Segment Reporting Information [Line Items]
Net Sales	8,141	7,078	25,732		20,491
Gross Profit	2,618	2,493	8,348		7,156
Healthcare
Segment Reporting Information [Line Items]
Net Sales	3,135	2,920	8,481		7,556
Gross Profit	$ 788	$ 965	$ 2,095		$ 1,782

XML

Segment Reporting - Schedule of Net Sales and Gross Profit by Geographic Region (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Feb. 26, 2022	Feb. 27, 2021	Feb. 26, 2022	Feb. 26, 2022	Feb. 27, 2021	Feb. 27, 2021
Segment Reporting Information [Line Items]
Net Sales		$ 55,308	$ 45,235	$ 162,991	$ 162,991	$ 126,465	$ 126,465
Gross Profit		17,569	15,766	51,523	$ 51,523	42,468	$ 42,468
North America
Segment Reporting Information [Line Items]
Net Sales		23,647	19,654	68,615		53,513
Gross Profit		8,946	8,081	24,984		21,099
Asia/Pacific
Segment Reporting Information [Line Items]
Net Sales		13,275	9,821	38,220		28,970
Gross Profit		4,061	3,517	12,126		9,592
Europe
Segment Reporting Information [Line Items]
Net Sales		16,067	13,285	48,231		37,277
Gross Profit		4,884	4,356	14,507		12,153
Latin America
Segment Reporting Information [Line Items]
Net Sales		2,380	2,446	7,976		6,591
Gross Profit		917	896	2,998		2,345
Other
Segment Reporting Information [Line Items]
Net Sales	[1]	(61)	29	(51)		114
Gross Profit	[1]	$ (1,239)	$ (1,084)	$ (3,092)		$ (2,721)

[1] Other includes primarily net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.

XML

Risks and Uncertainties - Additional Information (Details) $ in Millions	9 Months Ended
	Feb. 26, 2022 USD ($)
Risks And Uncertainties [Abstract]
Deferred employer social security tax payments	$ 0.5

XML

Fair Value Measurements - Additional Information (Details) - USD ($)	Feb. 26, 2022	May 29, 2021
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments measured at fair value	$ 0	$ 0

XML

Related Party Transaction - Additional Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Feb. 26, 2022	Feb. 27, 2021
Related Party Transaction [Line Items]
Total future minimum lease payments	$ 3,475
Rental expense	986	$ 430
Lessor - LDL, LLC | Lee A. McIntyre III
Related Party Transaction [Line Items]
Total future minimum lease payments	$ 500
Lease term	5 years
Renewal term	5 years
Extended term	5 years
Rental expense	$ 100	$ 100